
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="8E59E51492652F633AE514006B3161C6.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="frontonco">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10470619/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Frontiers in Oncology">
<meta name="citation_title" content="Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru">
<meta name="citation_author" content="Yomali Ferreyra">
<meta name="citation_author_institution" content="Departamento de Bioingeniería, Universidad de Ingenieria y Tecnología, Lima, Peru">
<meta name="citation_author" content="Gina Rosas">
<meta name="citation_author_institution" content="Departamento de Patología, Insituto Nacional de Enfermedades Neoplásicas, Lima, Peru">
<meta name="citation_author" content="Alicia M Cock-Rada">
<meta name="citation_author_institution" content="Departmento de Oncología Médica, Instituto de Cancerología Las Américas - Auna, Medellín, Colombia">
<meta name="citation_author" content="Jhajaira Araujo">
<meta name="citation_author_institution" content="Centro de Investigación Básicas y traslacional, Auna Ideas, Lima, Peru">
<meta name="citation_author" content="Leny Bravo">
<meta name="citation_author_institution" content="Escuela Profesional de Medicina Humana-Filial Ica, Universidad Privada San Juan Bautista, Ica, Peru">
<meta name="citation_author" content="Franco Doimi">
<meta name="citation_author_institution" content="Oncogenomics, Auna, Lima, Peru">
<meta name="citation_author" content="Jhoysi Casas">
<meta name="citation_author_institution" content="Oncogenomics, Auna, Lima, Peru">
<meta name="citation_author" content="María de los Ángeles Clavo">
<meta name="citation_author_institution" content="Facultad de Medicina Humana, Universidad Nacional San Luis Gonzaga, Ica, Peru">
<meta name="citation_author" content="Joseph A Pinto">
<meta name="citation_author_institution" content="Centro de Investigación Básicas y traslacional, Auna Ideas, Lima, Peru">
<meta name="citation_author" content="Carolina Belmar-López">
<meta name="citation_author_institution" content="Escuela Profesional de Medicina Humana-Filial Ica, Universidad Privada San Juan Bautista, Ica, Peru">
<meta name="citation_author_institution" content="Oncogenomics, Auna, Lima, Peru">
<meta name="citation_publication_date" content="2023 Aug 17">
<meta name="citation_volume" content="13">
<meta name="citation_firstpage" content="1227864">
<meta name="citation_doi" content="10.3389/fonc.2023.1227864">
<meta name="citation_pmid" content="37664050">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC10470619/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC10470619/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC10470619/pdf/fonc-13-1227864.pdf">
<meta name="description" content="There is an increasing amount of data from Latin America on the characterization of BRCA variants; however, there is limited information from Peru. We conducted a retrospective study to describe germline pathogenic/likely pathogenic(P/LP) variants ...">
<meta name="og:title" content="Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="There is an increasing amount of data from Latin America on the characterization of BRCA variants; however, there is limited information from Peru. We conducted a retrospective study to describe germline pathogenic/likely pathogenic(P/LP) variants ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC10470619/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="10470619">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.3389/fonc.2023.1227864"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/fonc-13-1227864.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC10470619%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/10470619/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/10470619/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC10470619/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-frontonco.gif" alt="Frontiers in Oncology logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Frontiers in Oncology" title="Link to Frontiers in Oncology" shape="default" href="http://www.frontiersin.org/oncology" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Front Oncol</button></div>. 2023 Aug 17;13:1227864. doi: <a href="https://doi.org/10.3389/fonc.2023.1227864" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.3389/fonc.2023.1227864</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Front%20Oncol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Front%20Oncol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Front%20Oncol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Front%20Oncol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Landscape of germline <em>BRCA1/BRCA2</em> variants in breast and ovarian cancer in Peru</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ferreyra%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Yomali Ferreyra</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Yomali Ferreyra</span></h3>
<div class="p">
<sup>1</sup>
Departamento de Bioingeniería, Universidad de Ingenieria y Tecnología, Lima, Peru
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ferreyra%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yomali Ferreyra</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rosas%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Gina Rosas</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Gina Rosas</span></h3>
<div class="p">
<sup>2</sup>
Departamento de Patología, Insituto Nacional de Enfermedades Neoplásicas, Lima, Peru
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rosas%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Gina Rosas</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cock-Rada%20AM%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Alicia M Cock-Rada</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Alicia M Cock-Rada</span></h3>
<div class="p">
<sup>3</sup>
Departmento de Oncología Médica, Instituto de Cancerología Las Américas - Auna, Medellín, Colombia
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cock-Rada%20AM%22%5BAuthor%5D" class="usa-link"><span class="name western">Alicia M Cock-Rada</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Araujo%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Jhajaira Araujo</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Jhajaira Araujo</span></h3>
<div class="p">
<sup>4</sup>
Centro de Investigación Básicas y traslacional, Auna Ideas, Lima, Peru
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Araujo%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jhajaira Araujo</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bravo%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Leny Bravo</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Leny Bravo</span></h3>
<div class="p">
<sup>5</sup>
Escuela Profesional de Medicina Humana-Filial Ica, Universidad Privada San Juan Bautista, Ica, Peru
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bravo%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Leny Bravo</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Doimi%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Franco Doimi</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Franco Doimi</span></h3>
<div class="p">
<sup>6</sup>
Oncogenomics, Auna, Lima, Peru
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Doimi%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Franco Doimi</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Casas%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Jhoysi Casas</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Jhoysi Casas</span></h3>
<div class="p">
<sup>6</sup>
Oncogenomics, Auna, Lima, Peru
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Casas%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jhoysi Casas</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Clavo%20MDL%C3%81%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">María de los Ángeles Clavo</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">María de los Ángeles Clavo</span></h3>
<div class="p">
<sup>7</sup>
Facultad de Medicina Humana, Universidad Nacional San Luis Gonzaga, Ica, Peru
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Clavo%20MDL%C3%81%22%5BAuthor%5D" class="usa-link"><span class="name western">María de los Ángeles Clavo</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pinto%20JA%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Joseph A Pinto</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Joseph A Pinto</span></h3>
<div class="p">
<sup>4</sup>
Centro de Investigación Básicas y traslacional, Auna Ideas, Lima, Peru
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pinto%20JA%22%5BAuthor%5D" class="usa-link"><span class="name western">Joseph A Pinto</span></a>
</div>
</div>
<sup>4,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Belmar-L%C3%B3pez%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Carolina Belmar-López</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Carolina Belmar-López</span></h3>
<div class="p">
<sup>5</sup>
Escuela Profesional de Medicina Humana-Filial Ica, Universidad Privada San Juan Bautista, Ica, Peru
</div>
<div class="p">
<sup>6</sup>
Oncogenomics, Auna, Lima, Peru
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Belmar-L%C3%B3pez%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Carolina Belmar-López</span></a>
</div>
</div>
<sup>5,</sup><sup>6</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>1</sup>
Departamento de Bioingeniería, Universidad de Ingenieria y Tecnología, Lima, Peru
</div>
<div id="aff2">
<sup>2</sup>
Departamento de Patología, Insituto Nacional de Enfermedades Neoplásicas, Lima, Peru
</div>
<div id="aff3">
<sup>3</sup>
Departmento de Oncología Médica, Instituto de Cancerología Las Américas - Auna, Medellín, Colombia
</div>
<div id="aff4">
<sup>4</sup>
Centro de Investigación Básicas y traslacional, Auna Ideas, Lima, Peru
</div>
<div id="aff5">
<sup>5</sup>
Escuela Profesional de Medicina Humana-Filial Ica, Universidad Privada San Juan Bautista, Ica, Peru
</div>
<div id="aff6">
<sup>6</sup>
Oncogenomics, Auna, Lima, Peru
</div>
<div id="aff7">
<sup>7</sup>
Facultad de Medicina Humana, Universidad Nacional San Luis Gonzaga, Ica, Peru
</div>
<div class="author-notes p">
<div class="fn" id="fn1"><p>Edited by: Charles Theillet, Institut du Cancer de Montpellier (ICM), France</p></div>
<div class="fn" id="fn2"><p>Reviewed by: Ekaterina Kuligina, N.N. Petrov National Medical Research Center of Oncology, Russia; Alvaro Galli, National Research Council (CNR), Italy</p></div>
<div class="fn" id="fn001">
<sup>✉</sup><p class="display-inline">*Correspondence: Joseph A. Pinto, <span>jpinto@gecoperu.org</span>
</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2023 May 23; Accepted 2023 Jul 27; Collection date 2023.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright © 2023 Ferreyra, Rosas, Cock-Rada, Araujo, Bravo, Doimi, Casas, Clavo, Pinto and Belmar-López</div>
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC10470619  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37664050/" class="usa-link">37664050</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background</h3>
<p>There is an increasing amount of data from Latin America on the characterization of BRCA variants; however, there is limited information from Peru. We conducted a retrospective study to describe germline pathogenic/likely pathogenic(P/LP) variants and variants of uncertain/unknown significance (VUS) in the BRCA1 and BRCA2 genes in Peru, in patients with breast and ovarian cancer, candidates for treatment with poly (adenosine diphosphate–ribose) polymerase (PARP) inhibitors.</p></section><section id="sec2"><h3 class="pmc_sec_title">Methods</h3>
<p>The patients were evaluated during the period 2019-2021. Genomic DNA was isolated from peripheral blood samples and targeted sequencing was performed using the Ampliseq BRCA panel. Genetic variant interpretation was carried out in accordance with the recommendations of the American College of Medical Genetics and ClinVar. During this period, 525 patients (143 with breast cancer and 382 with ovarian cancer) were studied. </p></section><section id="sec3"><h3 class="pmc_sec_title">Results</h3>
<p>We found that 14.7% (21/143) of breast cancer patients and 20.7% (79/382) of ovarian cancer patients were carriers of P/LP variants in BRCA1/2. The most frequent pathogenic variants detected in BRCA1 were c.2105dupT (BIC: 2224insT, n=12, 18.75%), c.68_69delAG (BIC: 185delAG, n=6, 9.38%), c.140G&gt;T and c.815_824dupAGCCATGTGG (n=5, 7.81%), while in BRCA2 were c.8023A&gt;G (n=6, 16.67%), c.6024dupG (BIC: 6252insG, n=4, 11.11%), and c.9235delG (BIC: 9463delG, n=3, 8.33%). Regarding VUS, we found that 6.99% (10/143) of breast cancer patients and 7.33% (28/382) of ovarian cancer patients were carriers of a VUS in BRCA1/2. For BRCA1, the most frequent VUS was c.93C&gt;G (n=2), and for BRCA2, c.5465A&gt;T (n=4), c.3101T&gt;C (n=3), c.205C&gt;A and c.437T&gt;C (n=2). </p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusion</h3>
<p>We found a frequency of 14.7% germline mutations in breast cancer patients and 20.7% in ovarian cancer patients. The most recurrent mutations were BRCA1 c.2105dupT and BRCA2 c.8023A&gt;G. We found that BRCA2 c.8023A&gt;G, c.6024dupG, and c.9235delG were not previously reported in Peruvian patients. BRCA1 c.2344dupA is a novel mutation that has not been previously reported in any database. The frequency of VUS in our cohort was 7.2%.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> breast cancer, ovarian cancer, BRCA1, BRCA2, germline mutation</p></section></section><section id="s1"><h2 class="pmc_sec_title">Background</h2>
<p>Breast and ovarian cancer are highly prevalent malignancies in Latin America, where more than 50 thousand patients die yearly from these pathologies. It is estimated that 5-10% of breast cancer (BC) and 10-15% of ovarian cancer (OC) are attributed to hereditary breast and ovarian cancer (HBOC). Mutations in the <em>BRCA1</em> and <em>BRCA2</em> genes are the best-known genetic risk factors for breast and ovarian cancer (<a href="#B1" class="usa-link" aria-describedby="B1">1</a>–<a href="#B3" class="usa-link" aria-describedby="B3">3</a>).</p>
<p>Detecting <em>BRCA1/2</em> mutations allows crucial and challenging decisions regarding cancer prevention or risk reduction, early detection and pharmacological management. Germline <em>BRCA1/2</em> variants cause hereditary breast and ovarian cancer syndrome and confer a lifetime risk of 38-87% of developing breast cancer in women and 16.5-63% of developing ovarian cancer (<a href="#B4" class="usa-link" aria-describedby="B4">4</a>). Germline <em>BRCA1/2</em> mutations are present in approximately 5% of all breast patients and 15% of all ovarian cancer patients (<a href="#B5" class="usa-link" aria-describedby="B5">5</a>, <a href="#B6" class="usa-link" aria-describedby="B6">6</a>). Breast tumors with <em>BRCA1/2</em> mutation carriers are more frequently HER2 negative, and triple-negative tumors (TNBC) account for approximately 68% of <em>BRCA1</em> tumors (<a href="#B7" class="usa-link" aria-describedby="B7">7</a>). High-grade serous ovarian cancers are more commonly associated with <em>BRCA1/2</em> mutations (<a href="#B8" class="usa-link" aria-describedby="B8">8</a>).</p>
<p>
<em>BRCA1/2</em> are tumor suppressor genes that participate in the homologous recombination repair of double-strand DNA damage. <em>BRCA1/2</em> defective cells are more sensitive to Poly(ADP-ribose) polymerase (PARP), an enzyme involved in base excision repair, a vital component of single-strand break repair (SSB). PARP inhibitors can increase SSB, which are converted to double-strand DNA breaks (DSBs) during replication. In defective <em>BRCA1/2</em> cells, these DSBs are not effectively repaired, leading to chromosomal instability, cell cycle arrest, and subsequent apoptosis, a mechanism known as synthetic lethality (<a href="#B9" class="usa-link" aria-describedby="B9">9</a>)</p>
<p>Several PARP inhibitors have been developed to treat patients with breast, ovarian, pancreatic, and prostate cancer with <em>BRCA1/2</em> mutations. OlympiAD, a phase III randomized, controlled, open-label study trial, compared Olaparib, a PARP inhibitor, with non-platinum chemotherapy (CT) in metastatic breast cancer patients with germline <em>BRCA</em>1/2 mutations. Progression-free survival (PFS) was higher in patients receiving Olaparib than in those receiving CT (7.0 vs 2.2 months). The hazard ratio (HR) for disease progression or death was 0.58 (95% CI 0.43-0.80: P&lt; 0.001). The response rate was 59.9% in the Olaparib group and 28.8% in the CT group. An improvement in PFS was observed in all subtypes and was higher in TNBC patients (<a href="#B10" class="usa-link" aria-describedby="B10">10</a>).</p>
<p>The randomized phase III trial, EMBRACA, compared another PARP inhibitor, Talazoparib, with single-agent CT in patients with advanced breast cancer with <em>BRCA1/2</em> mutations. The median PFS was longer in the Talazoparib group than in the control group (8.6 months [95% CI, 7.2-9.3] vs 5.6 months [95% CI, 4.2-6.7]; HR=0.54 [95% CI 0.41-0.71; P &lt; 0.001] for disease progression or death. Based on these two trials, the FDA approved Olaparib and Talozaparib for HER2-negative patients with <em>BRCA1/2</em> mutations, and the NCCN guidelines recommend testing for <em>BRCA1/2</em> mutations in all patients with TNBC or metastatic breast cancer to identify candidates for PARP inhibitor therapy (<a href="#B11" class="usa-link" aria-describedby="B11">11</a>).</p>
<p>For ovarian cancer, germline testing for <em>BRCA</em>1/2 is informative for selecting patients for PARP inhibitor therapy. Around 50% of ovarian tumors are homologous recombination deficient (HRD) and 20% are associated with <em>BRCA1/2</em> mutations, germline (14%) or somatic (6%) (<a href="#B6" class="usa-link" aria-describedby="B6">6</a>). PARP inhibitor treatment is recommended for maintenance therapy for stage II-IV disease or persistent or recurrent disease in BRCA<em>1/2</em> mutated ovarian cancer (<a href="#B12" class="usa-link" aria-describedby="B12">12</a>). The SOLO-1 phase III trial showed an improvement in 3-year PFS with Olaparib versus Placebo as maintenance therapy for patients with a germline <em>variant BRCA1/2</em>, who had a complete or partial response (CR/PR) after platinum-based first-line chemotherapy (60% vs. 27%; P&lt;0.0001); HR=0.30 [95% CI, 0.23-0.41] (<a href="#B13" class="usa-link" aria-describedby="B13">13</a>). Other phase III studies with PARP inhibitor, PAOLA-1: Olaparib + Bevacizumab versus Placebo + Bevacizumab for maintenance therapy for patients with advanced disease who had CR/PR after platinum-based first-line chemotherapy, or PRIMA: Niraparib versus Placebo as maintenance therapy for patients with CR/PR after platinum first-line chemotherapy showed a notable improvement in median PFS, especially in patients with a germline <em>BRCA</em>1/2 mutation or HRD (22.1 vs 16.6 months and 21.9 months vs 10.4 months, respectively) (<a href="#B14" class="usa-link" aria-describedby="B14">14</a>, <a href="#B15" class="usa-link" aria-describedby="B15">15</a>).</p>
<p>There is increasing information on the molecular epidemiology of <em>BRCA1/2</em> genes in Latin America and several founder mutations have been identified (<a href="#B16" class="usa-link" aria-describedby="B16">16</a>). Founder mutations in Latin America have been reported in Mexico (<em>BRCA1</em> del exons 9-12), Brazil (<em>BRCA1</em> 5382insC and <em>BRCA2</em> c.156_157insAlu), and Colombia (<em>BRCA1</em> 3450del4, A1708E and <em>BRCA2</em> 3034del4) (<a href="#B17" class="usa-link" aria-describedby="B17">17</a>).</p>
<p>Unfortunately, there is a gap in information about the genetic epidemiology of breast and ovarian cancers in Peru. A limited number of publications describe the frequency of <em>BRCA1</em> and <em>BRCA2</em> mutations in Peru with studies with small sample sizes and in a particular group of patients (<a href="#B18" class="usa-link" aria-describedby="B18">18</a>). Here, we describe the frequency and spectrum of genetic variants (pathogenic/likely pathogenic P/LP and VUS) in <em>the BRCA1/2</em> genes in patients with BC and/or OC, profiled during 2019-2021 in a reference laboratory in Peru, for the identification of PARP inhibitor candidates.</p></section><section id="s2"><h2 class="pmc_sec_title">Methods</h2>
<section id="s2_1"><h3 class="pmc_sec_title">Study population</h3>
<p>The study included all BC and OC patients, referred to Oncogenomics Laboratory (Lima, Peru) from 2019 to 2021, to identify candidates for PARP inhibitors treatment. The histological tumor types, hormone receptor and human epidermal growth factor receptor 2 (HER2) statuses were recorded.</p></section><section id="s2_2"><h3 class="pmc_sec_title">
<em>BRCA1/2</em> mutation screening</h3>
<p>Peripheral blood samples were taken to assess mutations in <em>the BRCA1/2</em> genes. DNA was extracted using the ReliaPrep Blood gDNA Miniprep System or the ReliaPrep FFPE gDNA Miniprep System (Promega, Madison, USA) according to the manufacturer’s protocol. DNA concentration was determined by fluorometric quantitation using a Qubit 4.0 fluorimeter with Qubit dsDNA HS ASSAY KIT (Invitrogen, USA). The panel targets single nucleotide variants (SNVs) and insertion/deletions (indels) in all exonic regions of the <em>BRCA1</em> and <em>BRCA2</em> genes and flanking intronic sequences. A commercial reference standard, Horizon Quantitative Multiplex Reference Standard HD810 was tested to validate the performance of NGS that detect mutations. Libraries were prepared using the Ampliseq <em>BRCA</em> Panel and Ampliseq Library PLUS (Illumina, San Diego, USA) following the manufacturer’s protocol without modifications using 10 ng of input DNA per sample. The multiplex polymerase chain reaction (PCR) was performed in 18 cycles. Sequencing adapters with unique indexes (AmpliSeq CD Indexes Set A for Illumina) were ligated to the amplification products and purified using Agencourt AmpureXP beads (Beckman Coulter, CA, USA) according to the manufacturer’s instructions. Libraries with 2nM molarities were subjected to clustering using a standard flow cell and sequenced on the Illumina MiSeq platform using the MiSeq Reagent Micro Kit v2 (300 cycles). Raw data were processed automatically in the BaseSpace Sequence Hub (Illumina) and aligned with the hg19 reference genome. An average of 95.7% (91.7– 99.8%) on-target reads, 96.6% (94.7 – 98.6%) read uniformity and 50X average coverage per sample were obtained.</p></section><section id="s2_3"><h3 class="pmc_sec_title">Mutation nomenclature and classification</h3>
<p>BaseSpace Variant Interpreter (Illumina) annotated and interpreted genetic variants. Genetic variants were annotated under the nomenclature of the Human Genome Variation Society (HGVS). Interpretation was made using the single nucleotide polymorphism database (dbSNP), breast cancer information core (BIC) and Clinvar database. The Integrative Genomics Viewer was applied to visualize the variants. All identified variants were checked with Varsome (Saphetor, Swiss).</p>
<p>Interpreting the pathogenicity of the variants followed the latest recommendations of the American College of Medical Genetics (ACMG) and ClinVar. In cases of conflicting interpretations of pathogenicty (classified as pathogenic by at least one database and benign, likely benign, or VUS by others) between ACMG and ClinVar, ACMG classification was used. All new variants (missense, in frame and splicing) not yet reported in the databases consulted, were also considered VUS. Benign variants were not reported.</p></section><section id="s2_4"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p>We conducted a descriptive analysis. The frequency of variants identified in the <em>BRCA1/2</em> genes was calculated using RStudio. Packages such as <em>sf, ggplot2</em> and <em>ggrepel</em> were installed to obtain geographical maps of Peru, to observe the distribution of pathogenic variants according to the place of birth of the patients.</p></section></section><section id="s3"><h2 class="pmc_sec_title">Results</h2>
<section id="s3_1"><h3 class="pmc_sec_title">General characteristics of patients</h3>
<p>A total of 525 patients were included in this study (143 with BC and 382 with OC). Most of the patients were born in metropolitan Lima (58.1%), followed by patients from the coast (excluding metropolitan Lima, 28.0%), highlands (11.6%) and jungle (2.1%). Regarding the clinical characteristics of BC patients, 21.7% (n=31) had HER2-negative and hormone receptor positive tumors, while 78.3% (n=112) of the patients had HER2-negative and hormone receptor negative tumors (TNBC). Most of the OC (90.8%) were high-grade serous carcinomas. The frequency of clinical stage III was 33.6% and 50%, and clinical stage IV was 66.4% and 50% for BC and OC, respectively (<a href="#T1" class="usa-link">
<strong>Table 1</strong>
</a>). The prevalence of patients with P/LP germline variants in <em>BRCA1/2</em> was 19.0% (n=100/525). No patient had more than one P/LP variant. The percentage of BC patients who carried germline <em>BRCA1/2</em> P/LP variants was 14.7% (n=21/143) with 61.9% (n=13/21) of them carrying variants in <em>BRCA1</em> and 38.1% (n=8/21) in <em>BRCA2</em> (<a href="#f1" class="usa-link">
<strong>Figure 1</strong>
</a>). In total, 81% (n=17/21) of patients with <em>BRCA1/2</em> P/LP variants were TNBC and 19.1% (n=4/21) were positive for hormone receptors. Furthermore, 38.1% (n=8/21) were reported in clinical stage III and 61.9% (n=13/21) in clinical stage IV. Although we had no information about their age at the time of diagnosis, the mean age at molecular diagnosis was 48.63 years (range: 30-74 years).On the other hand, 20.7%(n=79/382) of OC patients had germline <em>BRCA1/2</em> P/LP variants with 64.8% (n=51/79) of them in <em>BRCA1</em> and 35.44% (n=28/79) in <em>BRCA2</em>. Regarding the histological subtypes of <em>BRCA1/2</em> OC patients, it was observed that 91.1% (n=72/79) were characterized by high-grade serous carcinoma, followed by endometrioid carcinoma (n=5/79, 6.3%) and clear cell carcinoma (n=2/79, 2.53%). The clinical stages were distributed in 49.4% (n=39/79) stage III and 50.6% (n=40/79) stage IV. Furthermore, only 77 patients had their age at molecular diagnosis available, so the mean age was 54.36 years (range: 34-77).</p>
<section class="tw xbox font-sm" id="T1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Clinicopathological characteristics of the general population.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th valign="top" colspan="2" align="center" rowspan="1">Clinical characteristics</th>
<th valign="top" align="center" rowspan="1" colspan="1">BC % (n=143)</th>
<th valign="top" align="center" rowspan="1" colspan="1">OC % (n=382)</th>
<th valign="top" align="center" rowspan="1" colspan="1">All patients (n=525)</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" rowspan="4" align="center" colspan="1">
<strong>BRCA1/2 status</strong>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>POSITIVE</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">21.7 (31)</td>
<td valign="top" align="center" rowspan="1" colspan="1">28.0 (107)</td>
<td valign="top" align="center" rowspan="1" colspan="1">26.3 (138)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">P/LP</td>
<td valign="top" align="center" rowspan="1" colspan="1">14.7 (21)</td>
<td valign="top" align="center" rowspan="1" colspan="1">20.7 (79)</td>
<td valign="top" align="center" rowspan="1" colspan="1">19.0 (100)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">VUS</td>
<td valign="top" align="center" rowspan="1" colspan="1">7.0 (10)</td>
<td valign="top" align="center" rowspan="1" colspan="1">7.3 (28)</td>
<td valign="top" align="center" rowspan="1" colspan="1">7.2 (38)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>NEGATIVE</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">78.3 (112)</td>
<td valign="top" align="center" rowspan="1" colspan="1">72.0 (275)</td>
<td valign="top" align="center" rowspan="1" colspan="1">73.7 (387)</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="center" colspan="1">
<strong>Clinical stage</strong>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">III</td>
<td valign="top" align="center" rowspan="1" colspan="1">33.6 (48)</td>
<td valign="top" align="center" rowspan="1" colspan="1">50.0 (191)</td>
<td valign="top" align="center" rowspan="1" colspan="1">45.5 (239)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">IV</td>
<td valign="top" align="center" rowspan="1" colspan="1">66.4 (95)</td>
<td valign="top" align="center" rowspan="1" colspan="1">50.0 (191)</td>
<td valign="top" align="center" rowspan="1" colspan="1">54.5 (286)</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="center" colspan="1">
<strong>IHC subtype</strong>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">HER2- HR-</td>
<td valign="top" align="center" rowspan="1" colspan="1">78.3 (112)</td>
<td valign="top" align="center" rowspan="1" colspan="1">—</td>
<td valign="top" align="center" rowspan="1" colspan="1">21.3 (112)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">HER2- HR+</td>
<td valign="top" align="center" rowspan="1" colspan="1">21.7 (31)</td>
<td valign="top" align="center" rowspan="1" colspan="1">—</td>
<td valign="top" align="center" rowspan="1" colspan="1">5.9 (31)</td>
</tr>
<tr>
<td valign="top" rowspan="5" align="center" colspan="1">
<strong>Histologic subtype</strong>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">High grade serous</td>
<td valign="top" align="center" rowspan="1" colspan="1">—</td>
<td valign="top" align="center" rowspan="1" colspan="1">90.8 (347)</td>
<td valign="top" align="center" rowspan="1" colspan="1">66.1 (347)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Low grade serous</td>
<td valign="top" align="center" rowspan="1" colspan="1">—</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.8 (3)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.6 (3)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Clear cell carcinoma</td>
<td valign="top" align="center" rowspan="1" colspan="1">—</td>
<td valign="top" align="center" rowspan="1" colspan="1">3.7 (14)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2.6 (14)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Endometrioid carcinoma</td>
<td valign="top" align="center" rowspan="1" colspan="1">—</td>
<td valign="top" align="center" rowspan="1" colspan="1">3.9 (15)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2.8 (15)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Others</td>
<td valign="top" align="center" rowspan="1" colspan="1">—</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.8 (3)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.6 (3)</td>
</tr>
<tr>
<td valign="top" rowspan="5" align="center" colspan="1">
<strong>Birthplace</strong>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">Metropolitan Lima</td>
<td valign="top" align="center" rowspan="1" colspan="1">64.3 (92)</td>
<td valign="top" align="center" rowspan="1" colspan="1">55.8 (213)</td>
<td valign="top" align="center" rowspan="1" colspan="1">58.1 (305)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Coast<sup>*</sup>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">25.2 (36)</td>
<td valign="top" align="center" rowspan="1" colspan="1">29.1 (111)</td>
<td valign="top" align="center" rowspan="1" colspan="1">28.0 (147)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Highlands</td>
<td valign="top" align="center" rowspan="1" colspan="1">8.4 (12)</td>
<td valign="top" align="center" rowspan="1" colspan="1">12.8 (49)</td>
<td valign="top" align="center" rowspan="1" colspan="1">11.6 (61)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Jungle</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.4 (2)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2.4 (9)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2.1 (11)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Unknown</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.7 (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.0 (0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.2 (1)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn3"><p>
<strong>*</strong>Excluding Metropolitan Lima.</p></div></div></section><figure class="fig xbox font-sm" id="f1"><h4 class="obj_head">Figure 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10470619_fonc-13-1227864-g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0791/10470619/303fb7b4cfb6/fonc-13-1227864-g001.jpg" loading="lazy" height="457" width="692" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/f1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Flowchart showing results and characteristics of patients with breast and ovarian cancer included in this study. P/LP, Pathogenic/likely pathogenic.</p></figcaption></figure></section><section id="s3_2"><h3 class="pmc_sec_title">Germline <em>BRCA1</em> pathogenic/likely pathogenic variants</h3>
<p>The study identified 33 different P/LP germline variants in <em>BRCA1</em> gene in 64 patients, finding 20.3% (n=13/64) in BC and 79.9% (n=51/64) in OC. The most frequent variants in <em>BRCA1</em> were c.2105dupT (BIC: 2224insT, n=12, 18.75%), c.68_69delAG (BIC: 185delAG, n=6, 9.38%), c.140G&gt;T and c.815 _824dupAGCCATGTGG (n=5, 7.81%) (<a href="#T2" class="usa-link">
<strong>Table 2</strong>
</a>). Most variants were previously reported, except <em>BRCA1</em> c.2344dupA (n=2, 2.74%), which was not reported in any database. These patients were born in Lima and Arequipa.</p>
<section class="tw xbox font-sm" id="T2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Pathogenic/likely pathogenic germline <em>BRCA1</em> variants found in our study.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left" rowspan="1" colspan="1">HGVSc Nomenclature</th>
<th valign="top" align="left" rowspan="1" colspan="1">HGVSp Nomenclature</th>
<th valign="top" align="center" rowspan="1" colspan="1">Effect</th>
<th valign="top" align="center" rowspan="1" colspan="1">Exon</th>
<th valign="top" align="center" rowspan="1" colspan="1">Frequency % (n=64)</th>
<th valign="top" align="center" rowspan="1" colspan="1">Tumor type</th>
<th valign="top" align="center" rowspan="1" colspan="1">Mutation type</th>
<th valign="top" align="center" rowspan="1" colspan="1">Reference</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">2105dupT</td>
<td valign="top" align="left" rowspan="1" colspan="1">Leu702Phefs*10</td>
<td valign="top" align="center" rowspan="1" colspan="1">L702Ffs*10</td>
<td valign="top" align="center" rowspan="1" colspan="1">10</td>
<td valign="top" align="center" rowspan="1" colspan="1">18.75% (12)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC (9), TNBC (3)</td>
<td valign="top" align="center" rowspan="1" colspan="1">inframe insertion</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">68_69delAG</td>
<td valign="top" align="left" rowspan="1" colspan="1">Glu23Valfs*17</td>
<td valign="top" align="center" rowspan="1" colspan="1">E23Vfs*17</td>
<td valign="top" align="center" rowspan="1" colspan="1">2</td>
<td valign="top" align="center" rowspan="1" colspan="1">9.38% (6)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC (5), TNBC (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">inframe deletion</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">140G&gt;T</td>
<td valign="top" align="left" rowspan="1" colspan="1">Cys47Phe</td>
<td valign="top" align="center" rowspan="1" colspan="1">C47F</td>
<td valign="top" align="center" rowspan="1" colspan="1">4</td>
<td valign="top" align="center" rowspan="1" colspan="1">7.81% (5)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC (4), TNBC (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">missense</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">815_824dupAGCCATGTGG</td>
<td valign="top" align="left" rowspan="1" colspan="1">Thr276Alafs*14</td>
<td valign="top" align="center" rowspan="1" colspan="1">T276Afs*14</td>
<td valign="top" align="center" rowspan="1" colspan="1">10</td>
<td valign="top" align="center" rowspan="1" colspan="1">7.81% (5)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">inframe insertion</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">5123C&gt;A</td>
<td valign="top" align="left" rowspan="1" colspan="1">Ala1708Glu</td>
<td valign="top" align="center" rowspan="1" colspan="1">A1708E</td>
<td valign="top" align="center" rowspan="1" colspan="1">17</td>
<td valign="top" align="center" rowspan="1" colspan="1">6.25% (4)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC (3), TNBC (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">missense</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">1961delA</td>
<td valign="top" align="left" rowspan="1" colspan="1">Lys654Serfs*47</td>
<td valign="top" align="center" rowspan="1" colspan="1">K654Sfs*47</td>
<td valign="top" align="center" rowspan="1" colspan="1">10</td>
<td valign="top" align="center" rowspan="1" colspan="1">4.69% (3)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC (2), BC (HER2- RH+, 1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">inframe deletion</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">2344dupA</td>
<td valign="top" align="left" rowspan="1" colspan="1">Ser782Lysfs*8</td>
<td valign="top" align="center" rowspan="1" colspan="1">S782Kfs*8</td>
<td valign="top" align="center" rowspan="1" colspan="1">10</td>
<td valign="top" align="center" rowspan="1" colspan="1">3.13% (2)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">inframe insertion</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">5251C&gt;T</td>
<td valign="top" align="left" rowspan="1" colspan="1">Arg1751*</td>
<td valign="top" align="center" rowspan="1" colspan="1">R1751*</td>
<td valign="top" align="center" rowspan="1" colspan="1">19</td>
<td valign="top" align="center" rowspan="1" colspan="1">3.13% (2)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC (1), TNBC (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">missense</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">62_66delTCTTA</td>
<td valign="top" align="left" rowspan="1" colspan="1">Ile21Argfs*18</td>
<td valign="top" align="center" rowspan="1" colspan="1">I21Rfs*18</td>
<td valign="top" align="center" rowspan="1" colspan="1">2</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.56% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">inframe deletion</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">211A&gt;G</td>
<td valign="top" align="left" rowspan="1" colspan="1">Arg71Gly</td>
<td valign="top" align="center" rowspan="1" colspan="1">R71G</td>
<td valign="top" align="center" rowspan="1" colspan="1">4</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.56% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">missense</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">250G&gt;T</td>
<td valign="top" align="left" rowspan="1" colspan="1">Glu84*</td>
<td valign="top" align="center" rowspan="1" colspan="1">E84*</td>
<td valign="top" align="center" rowspan="1" colspan="1">5</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.56% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">missense</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">798_799delTT</td>
<td valign="top" align="left" rowspan="1" colspan="1">Ser267Lysfs*19</td>
<td valign="top" align="center" rowspan="1" colspan="1">S267Kfs*19</td>
<td valign="top" align="center" rowspan="1" colspan="1">10</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.56% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">inframe deletion</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">928C&gt;T</td>
<td valign="top" align="left" rowspan="1" colspan="1">Gln310*</td>
<td valign="top" align="center" rowspan="1" colspan="1">Q310*</td>
<td valign="top" align="center" rowspan="1" colspan="1">10</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.56% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">TNBC</td>
<td valign="top" align="center" rowspan="1" colspan="1">missense</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">1088delA</td>
<td valign="top" align="left" rowspan="1" colspan="1">Asn363Ilefs*11</td>
<td valign="top" align="center" rowspan="1" colspan="1">N363Ifs*11</td>
<td valign="top" align="center" rowspan="1" colspan="1">10</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.56% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">inframe deletion</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">1700dupA</td>
<td valign="top" align="left" rowspan="1" colspan="1">Asn567Lysfs*3</td>
<td valign="top" align="center" rowspan="1" colspan="1">N567Kfs*3</td>
<td valign="top" align="center" rowspan="1" colspan="1">10</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.56% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">inframe insertion</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">2215A&gt;T</td>
<td valign="top" align="left" rowspan="1" colspan="1">Lys739*</td>
<td valign="top" align="center" rowspan="1" colspan="1">K739*</td>
<td valign="top" align="center" rowspan="1" colspan="1">10</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.56% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">missense</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">2493T&gt;G</td>
<td valign="top" align="left" rowspan="1" colspan="1">Tyr831*</td>
<td valign="top" align="center" rowspan="1" colspan="1">Y831*</td>
<td valign="top" align="center" rowspan="1" colspan="1">10</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.56% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">stop gained</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">2544delA</td>
<td valign="top" align="left" rowspan="1" colspan="1">Glu849Lysfs*44</td>
<td valign="top" align="center" rowspan="1" colspan="1">E849Kfs*44</td>
<td valign="top" align="center" rowspan="1" colspan="1">10</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.56% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">inframe deletion</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">2649_2650delAA</td>
<td valign="top" align="left" rowspan="1" colspan="1">Thr884Ilefs*18</td>
<td valign="top" align="center" rowspan="1" colspan="1">T884Ifs*18</td>
<td valign="top" align="center" rowspan="1" colspan="1">10</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.56% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">inframe deletion</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">2766delA</td>
<td valign="top" align="left" rowspan="1" colspan="1">Val923Leufs*77</td>
<td valign="top" align="center" rowspan="1" colspan="1">V923Lfs*77</td>
<td valign="top" align="center" rowspan="1" colspan="1">10</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.56% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">inframe deletion</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">2839A&gt;T</td>
<td valign="top" align="left" rowspan="1" colspan="1">Lys947*</td>
<td valign="top" align="center" rowspan="1" colspan="1">K947*</td>
<td valign="top" align="center" rowspan="1" colspan="1">10</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.56% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">missense</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">2901_2902dupTC</td>
<td valign="top" align="left" rowspan="1" colspan="1">Pro968Leufs*33</td>
<td valign="top" align="center" rowspan="1" colspan="1">P968Lfs*33</td>
<td valign="top" align="center" rowspan="1" colspan="1">10</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.56% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">inframe insertion</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">2913delT</td>
<td valign="top" align="left" rowspan="1" colspan="1">His971Glnfs*29</td>
<td valign="top" align="center" rowspan="1" colspan="1">H971Qfs*29</td>
<td valign="top" align="center" rowspan="1" colspan="1">10</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.56% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">inframe deletion</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">3005delA</td>
<td valign="top" align="left" rowspan="1" colspan="1">Asn1002Thrfs*22</td>
<td valign="top" align="center" rowspan="1" colspan="1">N1002Tfs*22</td>
<td valign="top" align="center" rowspan="1" colspan="1">10</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.56% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">inframe deletion</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">3455delA</td>
<td valign="top" align="left" rowspan="1" colspan="1">Asp1152Alafs*3</td>
<td valign="top" align="center" rowspan="1" colspan="1">D1152Afs*3</td>
<td valign="top" align="center" rowspan="1" colspan="1">10</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.56% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">TNBC</td>
<td valign="top" align="center" rowspan="1" colspan="1">inframe deletion</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">3626T&gt;A</td>
<td valign="top" align="left" rowspan="1" colspan="1">Leu1209*</td>
<td valign="top" align="center" rowspan="1" colspan="1">L1209*</td>
<td valign="top" align="center" rowspan="1" colspan="1">10</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.56% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">missense</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">3800T&gt;G</td>
<td valign="top" align="left" rowspan="1" colspan="1">Leu1267*</td>
<td valign="top" align="center" rowspan="1" colspan="1">L1267*</td>
<td valign="top" align="center" rowspan="1" colspan="1">10</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.56% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">missense</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">del exon 11</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">11</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.56% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">deletion variant</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">4327C&gt;T</td>
<td valign="top" align="left" rowspan="1" colspan="1">Arg1443*</td>
<td valign="top" align="center" rowspan="1" colspan="1">R1443*</td>
<td valign="top" align="center" rowspan="1" colspan="1">12</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.56% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">TNBC</td>
<td valign="top" align="center" rowspan="1" colspan="1">missense</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">4484G&gt;T</td>
<td valign="top" align="left" rowspan="1" colspan="1">Arg1495Met</td>
<td valign="top" align="center" rowspan="1" colspan="1">R1495M</td>
<td valign="top" align="center" rowspan="1" colspan="1">13</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.56% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">missense</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">5158C&gt;T</td>
<td valign="top" align="left" rowspan="1" colspan="1">Arg1720Trp</td>
<td valign="top" align="center" rowspan="1" colspan="1">R1720W</td>
<td valign="top" align="center" rowspan="1" colspan="1">18</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.56% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">missense</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">5266dupC</td>
<td valign="top" align="left" rowspan="1" colspan="1">Gln1756Profs*74</td>
<td valign="top" align="center" rowspan="1" colspan="1">Q1756Pfs*74</td>
<td valign="top" align="center" rowspan="1" colspan="1">19</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.56% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">TNBC</td>
<td valign="top" align="center" rowspan="1" colspan="1">inframe insertion</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">67_75delGAGTGTCCC</td>
<td valign="top" align="left" rowspan="1" colspan="1">Glu23_Pro25del</td>
<td valign="top" align="center" rowspan="1" colspan="1">E23_P25del</td>
<td valign="top" align="center" rowspan="1" colspan="1">2</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.56% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">TNBC</td>
<td valign="top" align="center" rowspan="1" colspan="1">inframe deletion</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar*</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>Furthermore, <em>BRCA1</em> P/LP variants were observed mainly in exon 10 (n=20/33), exon 19 (n = 3/33), and exon 2 and 4 (n=2/33). Most of the P/LP variants were missense (n=13/33) and in frame deletion variants (n=12/33), followed by frame insertions (n=6/33) and stop gained variants (n=1/33) (<a href="#T2" class="usa-link">
<strong>Table 2</strong>
</a>). There was only one case with a large deletion, specifically a deletion of exon 11 (n=1/33). Patients with P/LP variants in the <em>BRCA1</em> gene were born primarily in Metropolitan Lima (n=37/64), the coast (n=21/64) and the highlands (n=6/64). The most frequent P/LP variants in <em>BRCA1</em>, c.2105dupT (n=11) and c.68_69delAG (n=5) were found predominantly in patients born in Metropolitan Lima (<a href="#f2" class="usa-link">
<strong>Figure 2A</strong>
</a>). The position of P/LP variants in relation to the Brca1 protein is shown in <a href="#f3" class="usa-link">
<strong>Figure 3A</strong>
</a>.</p>
<figure class="fig xbox font-sm" id="f2"><h4 class="obj_head">Figure 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10470619_fonc-13-1227864-g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0791/10470619/5299d20a2c71/fonc-13-1227864-g002.jpg" loading="lazy" height="399" width="708" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/f2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Pathogenic/likely pathogenic germline <em>BRCA1/2</em> variants according to the place of birth <strong>(A)</strong> Germline <em>BRCA1</em> LP/P variants <strong>(B)</strong> Germline <em>BRCA2</em> LP/P variants.</p></figcaption></figure><figure class="fig xbox font-sm" id="f3"><h4 class="obj_head">Figure 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10470619_fonc-13-1227864-g003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0791/10470619/2e858b1f23b9/fonc-13-1227864-g003.jpg" loading="lazy" height="307" width="706" alt="Figure 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/f3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Maps presenting counts of pathogenic and likely pathogenic variants sites in <strong>(A)</strong> Brca1 and <strong>(B)</strong> Brca2 proteins.</p></figcaption></figure></section><section id="s3_3"><h3 class="pmc_sec_title">Germline <em>BRCA2</em> pathogenic/likely pathogenic variants</h3>
<p>We found 22 different P/LP variants in <em>BRCA2</em> among 36 patients, 22.2% (n=8/36) in BC and 77.8% (n=28/36) in OC. The most frequent mutations in <em>BRCA2</em> were c.8023A&gt;G (n=6, 16.67%), c.6024dupG (BIC: 6252insG, n=4, 11.11%), and c.9235delG (BIC: 9463delG, n=3, 8.33%) (<a href="#T3" class="usa-link">
<strong>Table 3</strong>
</a>). Likewise, most of the <em>BRCA2</em> P/LP variants were found only in OC patients (n=14/22, 63.63%), followed by both OC and BC patients (n=4/22, 18.18%) and only BC patients (n=4/22, 18.18%). Furthermore, <em>BRCA2</em> variants were mainly reported in exon 11 (n=9/22, 40.91%), predominantly inframe deletions (n=10/22), followed by inframe insertions (n=6/22) and missense variants (n=5/22) (<a href="#T3" class="usa-link">
<strong>Table 3</strong>
</a>). Only one large deletion was identified in exon 10. Patients with P/LP variations in <em>BRCA2</em> were born in Metropolitan Lima (n = 24/36), on the coast (n=9/36) and in the highlands (n=3/36) (<a href="#f2" class="usa-link">
<strong>Figure 2B</strong>
</a>). The position of P/LP variants in relation to the Brca<em>2</em> protein is shown in <a href="#f3" class="usa-link">
<strong>Figure 3B</strong>
</a>.</p>
<section class="tw xbox font-sm" id="T3"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>Pathogenic/likely pathogenic germline <em>BRCA2</em> variants found in our study.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left" rowspan="1" colspan="1">HGVSc <br>Nomenclature</th>
<th valign="top" align="left" rowspan="1" colspan="1">HGVSp <br>Nomenclature</th>
<th valign="top" align="center" rowspan="1" colspan="1">Effect</th>
<th valign="top" align="center" rowspan="1" colspan="1">Exon</th>
<th valign="top" align="center" rowspan="1" colspan="1">Frequency % (n=36)</th>
<th valign="top" align="center" rowspan="1" colspan="1">Tumor type</th>
<th valign="top" align="center" rowspan="1" colspan="1">Mutation type</th>
<th valign="top" align="center" rowspan="1" colspan="1">Reference</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">8023A&gt;G</td>
<td valign="top" align="left" rowspan="1" colspan="1">Ile2675Val</td>
<td valign="top" align="center" rowspan="1" colspan="1">I2675V</td>
<td valign="top" align="center" rowspan="1" colspan="1">18</td>
<td valign="top" align="center" rowspan="1" colspan="1">16.67% (6)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC (5), TNBC (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">missense</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">6024dupG</td>
<td valign="top" align="left" rowspan="1" colspan="1">Gln2009Alafs*9</td>
<td valign="top" align="center" rowspan="1" colspan="1">Q2009Afs*9</td>
<td valign="top" align="center" rowspan="1" colspan="1">11</td>
<td valign="top" align="center" rowspan="1" colspan="1">11.11% (4)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC (3), BC (HER2- RH+, 1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">inframe insertion</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">9235delG</td>
<td valign="top" align="left" rowspan="1" colspan="1">Val3079Phefs*4</td>
<td valign="top" align="center" rowspan="1" colspan="1">V3079Ffs*4</td>
<td valign="top" align="center" rowspan="1" colspan="1">24</td>
<td valign="top" align="center" rowspan="1" colspan="1">8.33% (3)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">inframe deletion</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">1797_1801delTTATA</td>
<td valign="top" align="left" rowspan="1" colspan="1">Tyr600Argfs*14</td>
<td valign="top" align="center" rowspan="1" colspan="1">Y600Rfs*14</td>
<td valign="top" align="center" rowspan="1" colspan="1">10</td>
<td valign="top" align="center" rowspan="1" colspan="1">5.56% (2)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC (1), TNBC (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">inframe deletion</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">3001dupT</td>
<td valign="top" align="left" rowspan="1" colspan="1">Ser1001Phefs*8</td>
<td valign="top" align="center" rowspan="1" colspan="1">S1001Ffs*8</td>
<td valign="top" align="center" rowspan="1" colspan="1">11</td>
<td valign="top" align="center" rowspan="1" colspan="1">5.56% (2)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">inframe insertion</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">3395_3396delAA</td>
<td valign="top" align="left" rowspan="1" colspan="1">Lys1132Thrfs*11</td>
<td valign="top" align="center" rowspan="1" colspan="1">K1132Tfs*11</td>
<td valign="top" align="center" rowspan="1" colspan="1">11</td>
<td valign="top" align="center" rowspan="1" colspan="1">5.56% (2)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC (1), TNBC (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">inframe deletion</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">9253dupA</td>
<td valign="top" align="left" rowspan="1" colspan="1">Thr3085Asnfs*26</td>
<td valign="top" align="center" rowspan="1" colspan="1">T3085Nfs*26</td>
<td valign="top" align="center" rowspan="1" colspan="1">24</td>
<td valign="top" align="center" rowspan="1" colspan="1">5.56% (2)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">inframe insertion</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">658_659delGT</td>
<td valign="top" align="left" rowspan="1" colspan="1">Val220Ilefs*4</td>
<td valign="top" align="center" rowspan="1" colspan="1">V220Ifs*4</td>
<td valign="top" align="center" rowspan="1" colspan="1">8</td>
<td valign="top" align="center" rowspan="1" colspan="1">2.78% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">inframe deletion</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">1097T&gt;G</td>
<td valign="top" align="left" rowspan="1" colspan="1">Leu366*</td>
<td valign="top" align="center" rowspan="1" colspan="1">L366*</td>
<td valign="top" align="center" rowspan="1" colspan="1">10</td>
<td valign="top" align="center" rowspan="1" colspan="1">2.78% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">missense</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">1228A&gt;T</td>
<td valign="top" align="left" rowspan="1" colspan="1">Lys410*</td>
<td valign="top" align="center" rowspan="1" colspan="1">K410*</td>
<td valign="top" align="center" rowspan="1" colspan="1">10</td>
<td valign="top" align="center" rowspan="1" colspan="1">2.78% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">missense</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">1310_1313delAAGA</td>
<td valign="top" align="left" rowspan="1" colspan="1">Lys437Ilefs*22</td>
<td valign="top" align="center" rowspan="1" colspan="1">K437Ifs*22</td>
<td valign="top" align="center" rowspan="1" colspan="1">10</td>
<td valign="top" align="center" rowspan="1" colspan="1">2.78% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">inframe deletion</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">del exon 10</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">10</td>
<td valign="top" align="center" rowspan="1" colspan="1">2.78% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">deletion variant</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">2979G&gt;A</td>
<td valign="top" align="left" rowspan="1" colspan="1">Trp993*</td>
<td valign="top" align="center" rowspan="1" colspan="1">W993*</td>
<td valign="top" align="center" rowspan="1" colspan="1">11</td>
<td valign="top" align="center" rowspan="1" colspan="1">2.78% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">TNBC</td>
<td valign="top" align="center" rowspan="1" colspan="1">missense</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">5130_5133delTGTA</td>
<td valign="top" align="left" rowspan="1" colspan="1">Tyr1710*</td>
<td valign="top" align="center" rowspan="1" colspan="1">Y1710*</td>
<td valign="top" align="center" rowspan="1" colspan="1">11</td>
<td valign="top" align="center" rowspan="1" colspan="1">2.78% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">inframe deletion</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">5200dupG</td>
<td valign="top" align="left" rowspan="1" colspan="1">Glu1734Glyfs*9</td>
<td valign="top" align="center" rowspan="1" colspan="1">E1734Gfs*9</td>
<td valign="top" align="center" rowspan="1" colspan="1">11</td>
<td valign="top" align="center" rowspan="1" colspan="1">2.78% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">inframe insertion</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">5303_5304delTT</td>
<td valign="top" align="left" rowspan="1" colspan="1">Leu1768Argfs*5</td>
<td valign="top" align="center" rowspan="1" colspan="1">L1768Rfs*5</td>
<td valign="top" align="center" rowspan="1" colspan="1">11</td>
<td valign="top" align="center" rowspan="1" colspan="1">2.78% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">inframe deletion</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">5616delA</td>
<td valign="top" align="left" rowspan="1" colspan="1">Val1873*</td>
<td valign="top" align="center" rowspan="1" colspan="1">V1873*</td>
<td valign="top" align="center" rowspan="1" colspan="1">11</td>
<td valign="top" align="center" rowspan="1" colspan="1">2.78% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">TNBC</td>
<td valign="top" align="center" rowspan="1" colspan="1">inframe deletion</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">6450dupA</td>
<td valign="top" align="left" rowspan="1" colspan="1">Val2151Serfs*25</td>
<td valign="top" align="center" rowspan="1" colspan="1">V2151Sfs*25</td>
<td valign="top" align="center" rowspan="1" colspan="1">11</td>
<td valign="top" align="center" rowspan="1" colspan="1">2.78% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">inframe insertion</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">8021dupA</td>
<td valign="top" align="left" rowspan="1" colspan="1">Ile2675Aspfs*6</td>
<td valign="top" align="center" rowspan="1" colspan="1">I2675Dfs*6</td>
<td valign="top" align="center" rowspan="1" colspan="1">18</td>
<td valign="top" align="center" rowspan="1" colspan="1">2.78% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">BC (HER2- RH+)</td>
<td valign="top" align="center" rowspan="1" colspan="1">inframe insertion</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">8752G&gt;T</td>
<td valign="top" align="left" rowspan="1" colspan="1">Glu2918*</td>
<td valign="top" align="center" rowspan="1" colspan="1">E2918*</td>
<td valign="top" align="center" rowspan="1" colspan="1">21</td>
<td valign="top" align="center" rowspan="1" colspan="1">2.78% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">BC (HER2- RH+)</td>
<td valign="top" align="center" rowspan="1" colspan="1">missense</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">9026_9030delATCAT</td>
<td valign="top" align="left" rowspan="1" colspan="1">Tyr3009Serfs*7</td>
<td valign="top" align="center" rowspan="1" colspan="1">Y3009Sfs*7</td>
<td valign="top" align="center" rowspan="1" colspan="1">23</td>
<td valign="top" align="center" rowspan="1" colspan="1">2.78% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">inframe deletion</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG/ClinVar</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">9077delA</td>
<td valign="top" align="left" rowspan="1" colspan="1">Gln3026Argfs*2</td>
<td valign="top" align="center" rowspan="1" colspan="1">Q3026Rfs*2</td>
<td valign="top" align="center" rowspan="1" colspan="1">23</td>
<td valign="top" align="center" rowspan="1" colspan="1">2.78% (1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">inframe deletion</td>
<td valign="top" align="center" rowspan="1" colspan="1">ACMG</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="s3_4"><h3 class="pmc_sec_title">BRCA1/2 germline VUS</h3>
<p>
<em>BRCA1/2</em> variants classified as VUS were found in 7.23% (n=38/525) of the total study population. Regarding <em>BRCA1</em>, eight different VUS were found, with an overall frequency in patients of 1.71% (n = 9/525). Most VUS were reported only in patients with OC (n= 7/8, 87.5%) with a low frequency per variant (n=1/9, 1.1%) and most of them occurred in exon 10. Two VUS had conflicting classifications between ClinVar and the ACMG guidelines: <em>BRCA1</em> c.93C&gt;G (n = 2/9, 2.22%) and <em>BRCA1</em> c.287A&gt;G (<a href="#SM1" class="usa-link">
<strong>Table S1</strong>
</a>). The overall frequency of VUS in <em>BRCA2</em> was 5.52% (n=29/525). We identified 21 different VUS in <em>BRCA2</em> and the most frequent were c.5465A&gt;T (n = 4, 13.79%), followed by c.3101T&gt;C (n = 3, 10.34%), c.205C&gt;A and c.437T&gt;C (n = 2, 6.89%). Similarly, many of the VUS occurred in exon 11 (n = 9/21, 42.86%) and were reported only in patients with OC (n = 14/21, 66.67%). Variants c.2274T&gt;G, c.3509C&gt;T, c.7617 + 6T&gt;C, c.7759C&gt;T, and c.8462T&gt;C had conflicting classifications between the ACMG guidelines and ClinVar (<a href="#SM1" class="usa-link">
<strong>Table S1</strong>
</a>). In addition the pathogenic scores of VUS founds in this study are also presented in <a href="#SM1" class="usa-link">
<strong>Table S1</strong>
</a>.</p></section></section><section id="s4"><h2 class="pmc_sec_title">Discussion</h2>
<p>Breast and ovarian cancers are malignancies with a high incidence and prevalence in Latin American women. Costs of treatment and disability adjusted life years directly impact public health systems and society. The management of BC and OC is rapidly evolving with the discovery of new treatments that offer an improved survival advantage, as seen in recent years with PARP inhibitors in <em>BRCA1/2</em> mutation carriers (<a href="#B19" class="usa-link" aria-describedby="B19">19</a>)</p>
<p>There is limited information on the molecular epidemiology of BRCA1/2 in Peru. Although a third of the Peruvian population lives in Lima, there are economic and geographic barriers that make it difficult for patients to access adequate cancer care, including molecular tests and genetic counseling (<a href="#B20" class="usa-link" aria-describedby="B20">20</a>). Our work has some limitations, for example, the underrepresentation of patients from several regions of Peru, which have socioeconomic and ancestry differences with respect to Lima. Another limitation that could cause bias is that the study population was selected for possible treatment with PARP inhibitors (e.g., advanced-stage cancer, HER2-negative breast cancer).</p>
<p>The study of <em>BRCA1/2</em> variants in these patients is crucial to identify candidates for these treatments, but is also important to manage their future cancer risks. Patients with <em>BRCA1/2</em> mutations and their families can benefit from cancer risk reduction or early cancer detection strategies, such as double mastectomy or high-risk follow-up for BC and bilateral salpingo-oophorectomy for OC (<a href="#B12" class="usa-link" aria-describedby="B12">12</a>).</p>
<p>Latin American countries usually have less infrastructure and resources for genetic testing and treatment of patients with <em>BRCA1/2</em> than developed countries, and many of the cancer drugs approved in other countries are not available (<a href="#B21" class="usa-link" aria-describedby="B21">21</a>). Therefore, genetic testing is not always performed when needed. The interpretation of genetic variants can be more difficult in less-studied populations, and there are no specific open databases for variants in cancer-predisposing genes in Hispanic patients.</p>
<p>
<em>BRCA1</em> c.2105dupT was the most frequently found variant in this study. It is located in the coding exon 10 and causes a translational frameshift with a predicted alternate stop codon. This alteration is expected to result in loss of function, according to ClinVar. Until now, this variant was previously reported in 6 of 44 (13.6%) mutated patients with ovarian cancer belonging to the Peruvian population. Furthermore, it was reported only once in the Canadian population. A similar variant, <em>BRCA1</em> c.2105dup, was identified in Caucasian and Hispanic individuals in a study that included only female carriers with pathogenic variants in <em>BRCA1</em>/2 <em>(</em>
<a href="#B22" class="usa-link" aria-describedby="B22">22</a>)</p>
<p>In our cohort, we observed the <em>BRCA1</em> c.68_69delAG mutation (185delAG), which occurs in exon 2 and creates a stop codon at position 39. This alteration leads to premature translation termination and significant protein truncation (<a href="#B23" class="usa-link" aria-describedby="B23">23</a>). Regarding its origin, it constitutes one of the primary founder mutations in the Ashkenazi Jewish population that arose 61 generations ago and was introduced into the Hispanic population 650 years ago (<a href="#B24" class="usa-link" aria-describedby="B24">24</a>). Currently, it has been reported among several other non-Jewish ethnic groups, such as Peruvians, Mexicans, Colombians, and Brazilians (<a href="#B25" class="usa-link" aria-describedby="B25">25</a>–<a href="#B28" class="usa-link" aria-describedby="B28">28</a>). A study in Peruvian patients diagnosed with breast cancer showed that 185delAG was the most common mutation found, observed in 7 of 13 carriers (54%). They also noted that two mutation carriers identified as of indigenous ancestry had the <em>BRCA1</em> 185delAG mutation (<a href="#B28" class="usa-link" aria-describedby="B28">28</a>). Unlike that study, we found that the mutation was observed in people born in Lima and Lambayeque. While it has not been determined whether they share an indigenous or Jewish ancestry, it is known that although the 185delAG mutation resides in a common haplotype among Ashkenazi Jews, it also arose independently in at least two non-Jewish populations, such as those in Malaysia and the United Kingdom. On the other hand, the <em>BRCA1</em> c.140G&gt;T mutation is a missense variant, which occurs within exon 5 and the RING domain. It was previously reported as a VUS in Peruvian families with hereditary breast and ovarian cancer (<a href="#B18" class="usa-link" aria-describedby="B18">18</a>, <a href="#B24" class="usa-link" aria-describedby="B24">24</a>). However, it was also identified in the Norwegian population as a pathogenic and non-founder mutation (<a href="#B29" class="usa-link" aria-describedby="B29">29</a>).</p>
<p>The <em>BRCA1</em> c.815_824dupAGCCATGTGG variant is located in exon 10 and is the most common pathogenic variant reported in African Americans (<a href="#B30" class="usa-link" aria-describedby="B30">30</a>). This pathogenic variant results in a frameshift and a spurious stop codon of 14 amino acids downstream. Due to its African origin, the variant was found in inherited patients with BC from Senegal and its allele frequency was 27.7%. In that study, the variant was also detected in a control population of sporadic BC cases and healthy controls without cancer (allele frequency estimated at 5% and 0.55%, respectively) (<a href="#B31" class="usa-link" aria-describedby="B31">31</a>). This variant was also found in Latin American populations, such as Colombian, Peruvian and Mexican (<a href="#B18" class="usa-link" aria-describedby="B18">18</a>, <a href="#B32" class="usa-link" aria-describedby="B32">32</a>, <a href="#B33" class="usa-link" aria-describedby="B33">33</a>). In <a href="#T4" class="usa-link">
<strong>Table 4</strong>
</a>, we summarize and compare our findings with those of other populations. Because we evaluated a very specific group of patients, comparison of prevalence of P/LP variants with other populations it would not be appropriate.</p>
<section class="tw xbox font-sm" id="T4"><h3 class="obj_head">Table 4.</h3>
<div class="caption p"><p>Previous reports of <em>BRCA1/2</em> variants found in this study in different populations.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" rowspan="2" align="left" colspan="1">Most frequent BRCA 1/2 P/LP variants</th>
<th valign="top" colspan="6" align="center" rowspan="1">Populations</th>
<th valign="top" align="center" rowspan="1" colspan="1"></th>
</tr>
<tr>
<th valign="top" align="center" rowspan="1" colspan="1">Peruvian</th>
<th valign="top" align="center" rowspan="1" colspan="1">Latin American</th>
<th valign="top" align="center" rowspan="1" colspan="1">Asian</th>
<th valign="top" align="center" rowspan="1" colspan="1">American</th>
<th valign="top" align="center" rowspan="1" colspan="1">European</th>
<th valign="top" align="center" rowspan="1" colspan="1">Jewish (Ashkenazi)</th>
<th valign="top" align="center" rowspan="1" colspan="1">Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">BRCA1 c.2105dupT</td>
<td valign="top" align="center" rowspan="1" colspan="1">x</td>
<td valign="top" align="center" rowspan="1" colspan="1">x</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">x</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">(<a href="#B22" class="usa-link" aria-describedby="B22">22</a>, <a href="#B34" class="usa-link" aria-describedby="B34">34</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">BRCA1 c.68_69delAG</td>
<td valign="top" align="center" rowspan="1" colspan="1">x</td>
<td valign="top" align="center" rowspan="1" colspan="1">x</td>
<td valign="top" align="center" rowspan="1" colspan="1">x</td>
<td valign="top" align="center" rowspan="1" colspan="1">x</td>
<td valign="top" align="center" rowspan="1" colspan="1">x</td>
<td valign="top" align="center" rowspan="1" colspan="1">x</td>
<td valign="top" align="left" rowspan="1" colspan="1">(<a href="#B22" class="usa-link" aria-describedby="B22">22</a>–<a href="#B25" class="usa-link" aria-describedby="B25">25</a>, <a href="#B27" class="usa-link" aria-describedby="B27">27</a>, <a href="#B33" class="usa-link" aria-describedby="B33">33</a>, <a href="#B35" class="usa-link" aria-describedby="B35">35</a>–<a href="#B45" class="usa-link" aria-describedby="B45">45</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">BRCA1 c.140G&gt;T</td>
<td valign="top" align="center" rowspan="1" colspan="1">x</td>
<td valign="top" align="center" rowspan="1" colspan="1">x</td>
<td valign="top" align="center" rowspan="1" colspan="1">x</td>
<td valign="top" align="center" rowspan="1" colspan="1">x</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">(<a href="#B18" class="usa-link" aria-describedby="B18">18</a>, <a href="#B29" class="usa-link" aria-describedby="B29">29</a>, <a href="#B36" class="usa-link" aria-describedby="B36">36</a>, <a href="#B46" class="usa-link" aria-describedby="B46">46</a>–<a href="#B48" class="usa-link" aria-describedby="B48">48</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">BRCA1 c.815_824dupAGCCATGTGG</td>
<td valign="top" align="center" rowspan="1" colspan="1">x</td>
<td valign="top" align="center" rowspan="1" colspan="1">x</td>
<td valign="top" align="center" rowspan="1" colspan="1">x</td>
<td valign="top" align="center" rowspan="1" colspan="1">x</td>
<td valign="top" align="center" rowspan="1" colspan="1">x</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">(<a href="#B18" class="usa-link" aria-describedby="B18">18</a>, <a href="#B31" class="usa-link" aria-describedby="B31">31</a>, <a href="#B33" class="usa-link" aria-describedby="B33">33</a>, <a href="#B35" class="usa-link" aria-describedby="B35">35</a>, <a href="#B49" class="usa-link" aria-describedby="B49">49</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">BRCA1 c.5123C&gt;A</td>
<td valign="top" align="center" rowspan="1" colspan="1">x</td>
<td valign="top" align="center" rowspan="1" colspan="1">x</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">x</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">(<a href="#B28" class="usa-link" aria-describedby="B28">28</a>, <a href="#B50" class="usa-link" aria-describedby="B50">50</a>–<a href="#B52" class="usa-link" aria-describedby="B52">52</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">BRCA1 c.1961delA</td>
<td valign="top" align="center" rowspan="1" colspan="1">x</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">x</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">(<a href="#B28" class="usa-link" aria-describedby="B28">28</a>, <a href="#B52" class="usa-link" aria-describedby="B52">52</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">BRCA1 c.2344dupA</td>
<td valign="top" align="center" rowspan="1" colspan="1">None</td>
<td valign="top" align="center" rowspan="1" colspan="1">None</td>
<td valign="top" align="center" rowspan="1" colspan="1">None</td>
<td valign="top" align="center" rowspan="1" colspan="1">None</td>
<td valign="top" align="center" rowspan="1" colspan="1">None</td>
<td valign="top" align="center" rowspan="1" colspan="1">None</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">BRCA1 c.5251C&gt;T</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">x</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">(<a href="#B53" class="usa-link" aria-describedby="B53">53</a>, <a href="#B54" class="usa-link" aria-describedby="B54">54</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">BRCA 2 c.8023A&gt;G</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">x</td>
<td valign="top" align="center" rowspan="1" colspan="1">x</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">x</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">(<a href="#B48" class="usa-link" aria-describedby="B48">48</a>, <a href="#B53" class="usa-link" aria-describedby="B53">53</a>–<a href="#B55" class="usa-link" aria-describedby="B55">55</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">BRCA2 c.6024dupG</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">x</td>
<td valign="top" align="center" rowspan="1" colspan="1">x</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">x</td>
<td valign="top" align="center" rowspan="1" colspan="1">x</td>
<td valign="top" align="left" rowspan="1" colspan="1">(<a href="#B45" class="usa-link" aria-describedby="B45">45</a>, <a href="#B55" class="usa-link" aria-describedby="B55">55</a>–<a href="#B60" class="usa-link" aria-describedby="B60">60</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">BRCA2 c.9235delG</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">x</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">(<a href="#B25" class="usa-link" aria-describedby="B25">25</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">BRCA2 c.1797_1801delTTATA</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">x</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">(<a href="#B61" class="usa-link" aria-describedby="B61">61</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">BRCA2 c.3395_3396delAA</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">x</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">(<a href="#B58" class="usa-link" aria-describedby="B58">58</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">BRCA2 c.9253dupA</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">x</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">(<a href="#B53" class="usa-link" aria-describedby="B53">53</a>)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>In conclusion, in this selected Peruvian population, we found a frequency of 14.7% <em>BRCA1/2</em> germline mutations in BC and 20.7% in OC. The most recurrent mutations were <em>BRCA1</em> c.2105dupT and BRCA2 c.8023A&gt;G. On the other hand, BRCA2 c.8023A&gt;G, c.6024dupG and c.9235delG were not previously reported in Peruvian patients. BRCA1 c.2344dupA is a novel mutation that has not been previously reported in any database.</p></section><section id="s6"><h2 class="pmc_sec_title">Data availability statement</h2>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/<a href="#SM1" class="usa-link">
<strong>Supplementary Material</strong>
</a>.</p></section><section id="s7"><h2 class="pmc_sec_title">Ethics statement</h2>
<p>The study was approved by the Institutional Review Board of the Universidad Privada San Juan Bautista (418-2021-CIEI-UPSJB) and conducted in compliance with all relevant ethical guidelines. Due to the retrospective nature of the study, the informed consent was waived.</p></section><section id="s5"><h2 class="pmc_sec_title">Author contributions</h2>
<p>CB-L, JC, and FD conducted molecular assays and collected the data. CB-L, FD, YF, GR, and AC-R conducted analysis of variants. YF, GR, JA, LB, and JP conducted statistical analysis. MC conducted the bioinformatic analysis. YF, GR, JA, LB, and JP prepared <a href="#T1" class="usa-link">
<strong>Tables 1</strong>
</a>, <a href="#T2" class="usa-link">
<strong>2</strong>
</a>. YF, GR, JA, LB, and JP prepared <a href="#f1" class="usa-link">
<strong>Figures 1</strong>
</a>-<a href="#f3" class="usa-link">
<strong>3</strong>
</a>. All authors wrote the manuscript. All authors contributed to the article and approved the submitted version.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Abbreviations</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn4"><p>VUS, Variants of Uncertain/Unknown Significance; PARP, Poly (Adenosine Diphosphate–Ribose) Polymerase; BC, Breast Cancer; OC, Ovarian Cancer; HBOC, Hereditary Breast and Ovarian Cancer; SSB, single-strand break repair, DSBs, Double-Strand DNA Breaks; CT, Chemotherapy; PFS, Progression-free survival; TNBC, Triple Negative Patients; CR/PR, Complete or Partial Response; HRD, Homologous Recombination Deficient; HER2, Human Epidermal Growth Factor Receptor 2; P/PL, Pathogenic/Likely Pathogenic; SNVs, Single Nucleotide Variants; PCR, Polymerase Chain Reaction; HGVS, Human Genome Variation Society (HGVS); dbSNP, Single Nucleotide Polymorphism Database; BIC, Breast Cancer Information Core; ACMG, American College of Medical Genetics.</p></div></div></section><section id="s8"><h2 class="pmc_sec_title">Conflict of interest</h2>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></section><section id="s9"><h2 class="pmc_sec_title">Publisher’s note</h2>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></section><section id="s10"><h2 class="pmc_sec_title">Supplementary material</h2>
<p>The Supplementary Material for this article can be found online at: <a href="https://www.frontiersin.org/articles/10.3389/fonc.2023.1227864/full#supplementary-material" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.frontiersin.org/articles/10.3389/fonc.2023.1227864/full#supplementary-material</a>
</p>
<section class="sm xbox font-sm" id="SM1"><div class="media p"><div class="caption">
<a href="/articles/instance/10470619/bin/Table_1.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (12.9KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="SM2"><div class="media p"><div class="caption">
<a href="/articles/instance/10470619/bin/Table_2.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (57.6KB, xlsx) </sup>
</div></div></section></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="B1">
<span class="label">1.</span><cite>
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin (2021) 71(3):209–49. doi: 10.3322/caac.21660
</cite> [<a href="https://doi.org/10.3322/caac.21660" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33538338/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CA%20Cancer%20J%20Clin&amp;title=Global%20cancer%20statistics%202020:%20GLOBOCAN%20estimates%20of%20incidence%20and%20mortality%20worldwide%20for%2036%20cancers%20in%20185%20countries&amp;author=H%20Sung&amp;author=J%20Ferlay&amp;author=RL%20Siegel&amp;author=M%20Laversanne&amp;author=I%20Soerjomataram&amp;volume=71&amp;issue=3&amp;publication_year=2021&amp;pmid=33538338&amp;doi=10.3322/caac.21660&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2">
<span class="label">2.</span><cite>
Yoshida R. Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis. Breast Cancer (2021) 28(6):1167–80. doi: 10.1007/s12282-020-01148-2
</cite> [<a href="https://doi.org/10.1007/s12282-020-01148-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8514387/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32862296/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer&amp;title=Hereditary%20breast%20and%20ovarian%20cancer%20(HBOC):%20review%20of%20its%20molecular%20characteristics,%20screening,%20treatment,%20and%20prognosis&amp;author=R%20Yoshida&amp;volume=28&amp;issue=6&amp;publication_year=2021&amp;pmid=32862296&amp;doi=10.1007/s12282-020-01148-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3">
<span class="label">3.</span><cite>
Saleem M, Ghazali MB, Wahab MAMA, Yusoff NM, Mahsin H, Seng CE, et al. The BRCA1 and BRCA2 genes in early-onset breast cancer patients. Adv Exp Med Biol (2020) 1292:1–12. doi:  10.1007/5584_2018_147
</cite> [<a href="https://doi.org/10.1007/5584_2018_147" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29687286/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Adv%20Exp%20Med%20Biol&amp;title=The%20BRCA1%20and%20BRCA2%20genes%20in%20early-onset%20breast%20cancer%20patients&amp;author=M%20Saleem&amp;author=MB%20Ghazali&amp;author=MAMA%20Wahab&amp;author=NM%20Yusoff&amp;author=H%20Mahsin&amp;volume=1292&amp;publication_year=2020&amp;pages=1-12&amp;pmid=29687286&amp;doi=10.1007/5584_2018_147&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4">
<span class="label">4.</span><cite>
Petrucelli N, Daly MB, Pal T. BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer (2022). GeneReviews®. Available at: <a href="https://www.ncbi.nlm.nih.gov/books/NBK1247/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/books/NBK1247/</a> (Accessed cited 2023 Jul 11).</cite> [<a href="https://scholar.google.com/scholar_lookup?title=BRCA1-%20and%20BRCA2-Associated%20Hereditary%20Breast%20and%20Ovarian%20Cancer&amp;author=N%20Petrucelli&amp;author=MB%20Daly&amp;author=T%20Pal&amp;publication_year=2022&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5">
<span class="label">5.</span><cite>
Malone KE, Daling JR, Doody DR, Hsu L, Bernstein L, Coates RJ, et al. Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res (2006) 66(16):8297–308. doi: 10.1158/0008-5472.CAN-06-0503
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-06-0503" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16912212/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&amp;title=Prevalence%20and%20predictors%20of%20BRCA1%20and%20BRCA2%20mutations%20in%20a%20population-based%20study%20of%20breast%20cancer%20in%20white%20and%20black%20American%20women%20ages%2035%20to%2064%20years&amp;author=KE%20Malone&amp;author=JR%20Daling&amp;author=DR%20Doody&amp;author=L%20Hsu&amp;author=L%20Bernstein&amp;volume=66&amp;issue=16&amp;publication_year=2006&amp;pmid=16912212&amp;doi=10.1158/0008-5472.CAN-06-0503&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6">
<span class="label">6.</span><cite>
Konstantinopoulos PA, Ceccaldi R, Shapiro GI, D’Andrea AD. Homologous recombination deficiency: exploiting the fundamental vulnerability of ovarian cancer. Cancer Discovery (2015) 5(11):1137–54. doi: 10.1158/2159-8290.CD-15-0714
</cite> [<a href="https://doi.org/10.1158/2159-8290.CD-15-0714" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4631624/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26463832/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Discovery&amp;title=Homologous%20recombination%20deficiency:%20exploiting%20the%20fundamental%20vulnerability%20of%20ovarian%20cancer&amp;author=PA%20Konstantinopoulos&amp;author=R%20Ceccaldi&amp;author=GI%20Shapiro&amp;author=AD%20D%E2%80%99Andrea&amp;volume=5&amp;issue=11&amp;publication_year=2015&amp;pmid=26463832&amp;doi=10.1158/2159-8290.CD-15-0714&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7">
<span class="label">7.</span><cite>
Mavaddat N, Barrowdale D, Andrulis IL, Domchek SM, Eccles D, Nevanlinna H, et al. Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Cancer Epidemiol Biomarkers Prev (2012) 21(1):134–47. doi: 10.1158/1055-9965.EPI-11-0775
</cite> [<a href="https://doi.org/10.1158/1055-9965.EPI-11-0775" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3272407/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22144499/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Epidemiol%20Biomarkers%20Prev&amp;title=Pathology%20of%20breast%20and%20ovarian%20cancers%20among%20BRCA1%20and%20BRCA2%20mutation%20carriers:%20results%20from%20the%20Consortium%20of%20Investigators%20of%20Modifiers%20of%20BRCA1/2%20(CIMBA)&amp;author=N%20Mavaddat&amp;author=D%20Barrowdale&amp;author=IL%20Andrulis&amp;author=SM%20Domchek&amp;author=D%20Eccles&amp;volume=21&amp;issue=1&amp;publication_year=2012&amp;pmid=22144499&amp;doi=10.1158/1055-9965.EPI-11-0775&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8">
<span class="label">8.</span><cite>
Song H, Cicek MS, Dicks E, Harrington P, Ramus SJ, Cunningham JM, et al. The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population. Hum Mol Genet (2014) 23(17):4703–9. doi: 10.1093/hmg/ddu172
</cite> [<a href="https://doi.org/10.1093/hmg/ddu172" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4119409/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24728189/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Mol%20Genet&amp;title=The%20contribution%20of%20deleterious%20germline%20mutations%20in%20BRCA1,%20BRCA2%20and%20the%20mismatch%20repair%20genes%20to%20ovarian%20cancer%20in%20the%20population&amp;author=H%20Song&amp;author=MS%20Cicek&amp;author=E%20Dicks&amp;author=P%20Harrington&amp;author=SJ%20Ramus&amp;volume=23&amp;issue=17&amp;publication_year=2014&amp;pmid=24728189&amp;doi=10.1093/hmg/ddu172&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9">
<span class="label">9.</span><cite>
Farmer H, McCabe H, Lord CJ, Tutt AHJ, Johnson DA, Richardson TB, et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature (2005) 434(7035):917–21. doi: 10.1038/nature03445
</cite> [<a href="https://doi.org/10.1038/nature03445" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15829967/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Targeting%20the%20DNA%20repair%20defect%20in%20BRCA%20mutant%20cells%20as%20a%20therapeutic%20strategy&amp;author=H%20Farmer&amp;author=H%20McCabe&amp;author=CJ%20Lord&amp;author=AHJ%20Tutt&amp;author=DA%20Johnson&amp;volume=434&amp;issue=7035&amp;publication_year=2005&amp;pmid=15829967&amp;doi=10.1038/nature03445&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10">
<span class="label">10.</span><cite>
Robson M, Im SA, Senkus E, Xu B, Domchek SM, Masuda N, et al. Olaparib for metastatic breast cancer in patients with a germline BRCA mutation. N Engl J Med (2017) 377(6):523–33. doi: 10.1056/NEJMoa1706450
</cite> [<a href="https://doi.org/10.1056/NEJMoa1706450" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28578601/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Olaparib%20for%20metastatic%20breast%20cancer%20in%20patients%20with%20a%20germline%20BRCA%20mutation&amp;author=M%20Robson&amp;author=SA%20Im&amp;author=E%20Senkus&amp;author=B%20Xu&amp;author=SM%20Domchek&amp;volume=377&amp;issue=6&amp;publication_year=2017&amp;pmid=28578601&amp;doi=10.1056/NEJMoa1706450&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11">
<span class="label">11.</span><cite>
Litton JK, Rugo HS, Ettl J, Hurvitz SA, Gonçalves A, Lee KH, et al. Talazoparib in patients with advanced breast cancer and a germline BRCA mutation. New Engl J Med (2018) 379(8):753–63. doi:  10.1056/nejmoa1802905
</cite> [<a href="https://doi.org/10.1056/nejmoa1802905" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10600918/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30110579/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20Engl%20J%20Med&amp;title=Talazoparib%20in%20patients%20with%20advanced%20breast%20cancer%20and%20a%20germline%20BRCA%20mutation&amp;author=JK%20Litton&amp;author=HS%20Rugo&amp;author=J%20Ettl&amp;author=SA%20Hurvitz&amp;author=A%20Gon%C3%A7alves&amp;volume=379&amp;issue=8&amp;publication_year=2018&amp;pmid=30110579&amp;doi=10.1056/nejmoa1802905&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12">
<span class="label">12.</span><cite>
Gradishar WJ, Moran MS, Abraham J, Aft R, Agnese D, Allison KH, et al. Breast cancer, version 3.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw (2022) 20(6):691–722. doi:  10.6004/jnccn.2022.0030
</cite> [<a href="https://doi.org/10.6004/jnccn.2022.0030" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35714673/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Natl%20Compr%20Canc%20Netw&amp;title=Breast%20cancer,%20version%203.2022,%20NCCN%20clinical%20practice%20guidelines%20in%20oncology&amp;author=WJ%20Gradishar&amp;author=MS%20Moran&amp;author=J%20Abraham&amp;author=R%20Aft&amp;author=D%20Agnese&amp;volume=20&amp;issue=6&amp;publication_year=2022&amp;pages=691-722&amp;pmid=35714673&amp;doi=10.6004/jnccn.2022.0030&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13">
<span class="label">13.</span><cite>
Moore K, Colombo N, Scambia G, Kim BG, Oaknin A, Friedlander M, et al. Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer. N Engl J Med (2018) 379(26):2495–505. doi: 10.1056/NEJMoa1810858
</cite> [<a href="https://doi.org/10.1056/NEJMoa1810858" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30345884/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Maintenance%20olaparib%20in%20patients%20with%20newly%20diagnosed%20advanced%20ovarian%20cancer&amp;author=K%20Moore&amp;author=N%20Colombo&amp;author=G%20Scambia&amp;author=BG%20Kim&amp;author=A%20Oaknin&amp;volume=379&amp;issue=26&amp;publication_year=2018&amp;pmid=30345884&amp;doi=10.1056/NEJMoa1810858&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14">
<span class="label">14.</span><cite>
Ray-Coquard I, Pautier P, Pignata S, Pérol D, González-Martín A, Berger R, et al. Olaparib plus bevacizumab as first-line maintenance in ovarian cancer. New Engl J Med (2019) 381(25):2416–28. doi:  10.1056/nejmoa1911361
</cite> [<a href="https://doi.org/10.1056/nejmoa1911361" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31851799/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20Engl%20J%20Med&amp;title=Olaparib%20plus%20bevacizumab%20as%20first-line%20maintenance%20in%20ovarian%20cancer&amp;author=I%20Ray-Coquard&amp;author=P%20Pautier&amp;author=S%20Pignata&amp;author=D%20P%C3%A9rol&amp;author=A%20Gonz%C3%A1lez-Mart%C3%ADn&amp;volume=381&amp;issue=25&amp;publication_year=2019&amp;pmid=31851799&amp;doi=10.1056/nejmoa1911361&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15">
<span class="label">15.</span><cite>
González-Martín A, Pothuri B, Vergote I, DePont Christensen R, Graybill W, Mirza MR, et al. Niraparib in patients with newly diagnosed advanced ovarian cancer. New Engl J Med (2019) 381(25):2391–402. doi:  10.1056/NEJMoa1910962
</cite> [<a href="https://doi.org/10.1056/NEJMoa1910962" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31562799/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20Engl%20J%20Med&amp;title=Niraparib%20in%20patients%20with%20newly%20diagnosed%20advanced%20ovarian%20cancer&amp;author=A%20Gonz%C3%A1lez-Mart%C3%ADn&amp;author=B%20Pothuri&amp;author=I%20Vergote&amp;author=R%20DePont%20Christensen&amp;author=W%20Graybill&amp;volume=381&amp;issue=25&amp;publication_year=2019&amp;pmid=31562799&amp;doi=10.1056/NEJMoa1910962&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16">
<span class="label">16.</span><cite>
Zavala VA, Serrano-Gomez SJ, Dutil J, Fejerman L. Genetic epidemiology of breast cancer in Latin America. Genes (Basel) (2019) 10(2). doi: 10.3390/genes10020153
</cite> [<a href="https://doi.org/10.3390/genes10020153" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6410045/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30781715/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genes%20(Basel)&amp;title=Genetic%20epidemiology%20of%20breast%20cancer%20in%20Latin%20America&amp;author=VA%20Zavala&amp;author=SJ%20Serrano-Gomez&amp;author=J%20Dutil&amp;author=L%20Fejerman&amp;volume=10&amp;issue=2&amp;publication_year=2019&amp;pmid=30781715&amp;doi=10.3390/genes10020153&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17">
<span class="label">17.</span><cite>
Ossa CA, Torres D. Founder and recurrent mutations in BRCA1 and BRCA2 genes in Latin American countries: state of the art and literature review. Oncologist (2016) 21(7):832–9. doi: 10.1634/theoncologist.2015-0416
</cite> [<a href="https://doi.org/10.1634/theoncologist.2015-0416" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4943386/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27286788/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncologist&amp;title=Founder%20and%20recurrent%20mutations%20in%20BRCA1%20and%20BRCA2%20genes%20in%20Latin%20American%20countries:%20state%20of%20the%20art%20and%20literature%20review&amp;author=CA%20Ossa&amp;author=D%20Torres&amp;volume=21&amp;issue=7&amp;publication_year=2016&amp;pmid=27286788&amp;doi=10.1634/theoncologist.2015-0416&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18">
<span class="label">18.</span><cite>
Buleje J, Guevara-Fujita M, Acosta O, Huaman FDP, Danos P, Murillo A, et al. Mutational analysis of BRCA1 and BRCA2 genes in Peruvian families with hereditary breast and ovarian cancer. Mol Genet Genomic Med (2017) 5(5). doi: 10.1002/mgg3.301
</cite> [<a href="https://doi.org/10.1002/mgg3.301" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5606899/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28944232/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Genet%20Genomic%20Med&amp;title=Mutational%20analysis%20of%20BRCA1%20and%20BRCA2%20genes%20in%20Peruvian%20families%20with%20hereditary%20breast%20and%20ovarian%20cancer&amp;author=J%20Buleje&amp;author=M%20Guevara-Fujita&amp;author=O%20Acosta&amp;author=FDP%20Huaman&amp;author=P%20Danos&amp;volume=5&amp;issue=5&amp;publication_year=2017&amp;pmid=28944232&amp;doi=10.1002/mgg3.301&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19">
<span class="label">19.</span><cite>
Shao F, Duan Y, Zhao Y, Li Y, Liu J, Zhang C, et al. PARP inhibitors in breast and ovarian cancer with BRCA mutations: a meta-analysis of survival. Aging (2021) 13(6):8975–88. doi: 10.18632/aging.202724
</cite> [<a href="https://doi.org/10.18632/aging.202724" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8034970/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33705352/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Aging&amp;title=PARP%20inhibitors%20in%20breast%20and%20ovarian%20cancer%20with%20BRCA%20mutations:%20a%20meta-analysis%20of%20survival&amp;author=F%20Shao&amp;author=Y%20Duan&amp;author=Y%20Zhao&amp;author=Y%20Li&amp;author=J%20Liu&amp;volume=13&amp;issue=6&amp;publication_year=2021&amp;pmid=33705352&amp;doi=10.18632/aging.202724&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20">
<span class="label">20.</span><cite>
Pinto JA, Pinillos L, Villarreal-Garza C, Morante Z, Villarán MV, Mejía G, et al. Barriers in Latin America for the management of locally advanced breast cancer. Ecancermedicalscience (2019) 13. doi: 10.3332/ecancer.2019.897
</cite> [<a href="https://doi.org/10.3332/ecancer.2019.897" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6372299/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30792814/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ecancermedicalscience&amp;title=Barriers%20in%20Latin%20America%20for%20the%20management%20of%20locally%20advanced%20breast%20cancer&amp;author=JA%20Pinto&amp;author=L%20Pinillos&amp;author=C%20Villarreal-Garza&amp;author=Z%20Morante&amp;author=MV%20Villar%C3%A1n&amp;volume=13&amp;publication_year=2019&amp;pmid=30792814&amp;doi=10.3332/ecancer.2019.897&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21">
<span class="label">21.</span><cite>
Horgan D, Mia R, Erhabor T, Hamdi Y, Dandara C, Lal JA, et al. Fighting cancer around the world: A framework for action. Healthc (Basel) (2022) 10(11). doi: 10.3390/healthcare10112125
</cite> [<a href="https://doi.org/10.3390/healthcare10112125" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9690702/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36360466/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Healthc%20(Basel)&amp;title=Fighting%20cancer%20around%20the%20world:%20A%20framework%20for%20action&amp;author=D%20Horgan&amp;author=R%20Mia&amp;author=T%20Erhabor&amp;author=Y%20Hamdi&amp;author=C%20Dandara&amp;volume=10&amp;issue=11&amp;publication_year=2022&amp;pmid=36360466&amp;doi=10.3390/healthcare10112125&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22">
<span class="label">22.</span><cite>
Rebbeck TR, Friebel TM, Friedman E, Hamann U, Huo D, Kwong A, et al. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations. Hum Mutat (2018) 39(5):593–620. doi: 10.1002/humu.23406
</cite> [<a href="https://doi.org/10.1002/humu.23406" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5903938/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29446198/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Mutat&amp;title=Mutational%20spectrum%20in%20a%20worldwide%20study%20of%2029,700%20families%20with%20BRCA1%20or%20BRCA2%20mutations&amp;author=TR%20Rebbeck&amp;author=TM%20Friebel&amp;author=E%20Friedman&amp;author=U%20Hamann&amp;author=D%20Huo&amp;volume=39&amp;issue=5&amp;publication_year=2018&amp;pages=593-620&amp;pmid=29446198&amp;doi=10.1002/humu.23406&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23">
<span class="label">23.</span><cite>
Hartwig M, Janiszewska H, Bak A, Pilarska M, Heise M, Junkiert-Czarnecka A, et al. Prevalence of the BRCA1 c.68_69delAG (BIC: 185delAG) mutation in women with breast cancer from north-central Poland and a review of the literature on other regions of the country. Contemp Oncol (Pozn) (2013) 17(1):34–7. doi:  10.5114/wo.2013.33767
</cite> [<a href="https://doi.org/10.5114/wo.2013.33767" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3685350/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23788959/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Contemp%20Oncol%20(Pozn)&amp;title=Prevalence%20of%20the%20BRCA1%20c.68_69delAG%20(BIC:%20185delAG)%20mutation%20in%20women%20with%20breast%20cancer%20from%20north-central%20Poland%20and%20a%20review%20of%20the%20literature%20on%20other%20regions%20of%20the%20country&amp;author=M%20Hartwig&amp;author=H%20Janiszewska&amp;author=A%20Bak&amp;author=M%20Pilarska&amp;author=M%20Heise&amp;volume=17&amp;issue=1&amp;publication_year=2013&amp;pmid=23788959&amp;doi=10.5114/wo.2013.33767&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24">
<span class="label">24.</span><cite>
Laitman Y, Feng BJ, Zamir IM, Weitzel JN, Duncan P, Port D, et al. Haplotype analysis of the 185delAG BRCA1 mutation in ethnically diverse populations. Eur J Hum Genet (2013) 21(2):212–6. doi: 10.1038/ejhg.2012.124
</cite> [<a href="https://doi.org/10.1038/ejhg.2012.124" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3548269/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22763381/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Hum%20Genet&amp;title=Haplotype%20analysis%20of%20the%20185delAG%20BRCA1%20mutation%20in%20ethnically%20diverse%20populations&amp;author=Y%20Laitman&amp;author=BJ%20Feng&amp;author=IM%20Zamir&amp;author=JN%20Weitzel&amp;author=P%20Duncan&amp;volume=21&amp;issue=2&amp;publication_year=2013&amp;pmid=22763381&amp;doi=10.1038/ejhg.2012.124&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25">
<span class="label">25.</span><cite>
Villarreal-Garza C, Alvarez-Gómez RM, Pérez-Plasencia C, Herrera LA, Herzog J, Castillo D, et al. Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico. Cancer (2015) 121(3):372–8. doi: 10.1002/cncr.29058
</cite> [<a href="https://doi.org/10.1002/cncr.29058" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4304938/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25236687/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=Significant%20clinical%20impact%20of%20recurrent%20BRCA1%20and%20BRCA2%20mutations%20in%20Mexico&amp;author=C%20Villarreal-Garza&amp;author=RM%20Alvarez-G%C3%B3mez&amp;author=C%20P%C3%A9rez-Plasencia&amp;author=LA%20Herrera&amp;author=J%20Herzog&amp;volume=121&amp;issue=3&amp;publication_year=2015&amp;pmid=25236687&amp;doi=10.1002/cncr.29058&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26">
<span class="label">26.</span><cite>
Cock-Rada AM, Ossa CA, Garcia HI, Gomez LR. A multi-gene panel study in hereditary breast and ovarian cancer in Colombia. Fam Cancer (2018) 17(1):23–30. doi: 10.1007/s10689-017-0004-z
</cite> [<a href="https://doi.org/10.1007/s10689-017-0004-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28528518/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Fam%20Cancer&amp;title=A%20multi-gene%20panel%20study%20in%20hereditary%20breast%20and%20ovarian%20cancer%20in%20Colombia&amp;author=AM%20Cock-Rada&amp;author=CA%20Ossa&amp;author=HI%20Garcia&amp;author=LR%20Gomez&amp;volume=17&amp;issue=1&amp;publication_year=2018&amp;pages=23-30&amp;pmid=28528518&amp;doi=10.1007/s10689-017-0004-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27">
<span class="label">27.</span><cite>
Dillenburg CV, Bandeira IC, Tubino TV, Rossato LG, Dias ES, Bittelbrunn AC, et al. Prevalence of 185delAG and 5382insC mutations in BRCA1, and 6174delT in BRCA2 in women of Ashkenazi Jewish origin in southern Brazil. Genet Mol Biol (2012) 35(3):599–602. doi: 10.1590/S1415-47572012000400009
</cite> [<a href="https://doi.org/10.1590/S1415-47572012000400009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3459409/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23055798/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet%20Mol%20Biol&amp;title=Prevalence%20of%20185delAG%20and%205382insC%20mutations%20in%20BRCA1,%20and%206174delT%20in%20BRCA2%20in%20women%20of%20Ashkenazi%20Jewish%20origin%20in%20southern%20Brazil&amp;author=CV%20Dillenburg&amp;author=IC%20Bandeira&amp;author=TV%20Tubino&amp;author=LG%20Rossato&amp;author=ES%20Dias&amp;volume=35&amp;issue=3&amp;publication_year=2012&amp;pages=599-602&amp;pmid=23055798&amp;doi=10.1590/S1415-47572012000400009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28">
<span class="label">28.</span><cite>
Abugattas J, Llacuachaqui M, Allende YS, Velásquez AA, Velarde R, Cotrina J, et al. Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Peru. Clin Genet (2015) 88(4):371–5. doi: 10.1111/cge.12505
</cite> [<a href="https://doi.org/10.1111/cge.12505" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4374018/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25256238/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Genet&amp;title=Prevalence%20of%20BRCA1%20and%20BRCA2%20mutations%20in%20unselected%20breast%20cancer%20patients%20from%20Peru&amp;author=J%20Abugattas&amp;author=M%20Llacuachaqui&amp;author=YS%20Allende&amp;author=AA%20Vel%C3%A1squez&amp;author=R%20Velarde&amp;volume=88&amp;issue=4&amp;publication_year=2015&amp;pmid=25256238&amp;doi=10.1111/cge.12505&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29">
<span class="label">29.</span><cite>
Heramb C, Wangensteen T, Grindedal EM, Ariansen SL, Lothe S, Heimdal KR, et al. BRCA1 and BRCA2 mutation spectrum - an update on mutation distribution in a large cancer genetics clinic in Norway. Hered Cancer Clin Pract (2018) 16(1):1–15. doi:  10.1186/s13053-017-0085-6
</cite> [<a href="https://doi.org/10.1186/s13053-017-0085-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5761139/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29339979/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hered%20Cancer%20Clin%20Pract&amp;title=BRCA1%20and%20BRCA2%20mutation%20spectrum%20-%20an%20update%20on%20mutation%20distribution%20in%20a%20large%20cancer%20genetics%20clinic%20in%20Norway&amp;author=C%20Heramb&amp;author=T%20Wangensteen&amp;author=EM%20Grindedal&amp;author=SL%20Ariansen&amp;author=S%20Lothe&amp;volume=16&amp;issue=1&amp;publication_year=2018&amp;pages=1-15&amp;pmid=29339979&amp;doi=10.1186/s13053-017-0085-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B30">
<span class="label">30.</span><cite>
Scheuner MT, McNeel TS, Freedman AN. Population prevalence of familial cancer and common hereditary cancer syndromes. The 2005 California Health Interview Survey. Genet Med (2010) 12(11):726–35. doi:  10.1097/GIM.0b013e3181f30e9e
</cite> [<a href="https://doi.org/10.1097/GIM.0b013e3181f30e9e" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20921897/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet%20Med&amp;title=Population%20prevalence%20of%20familial%20cancer%20and%20common%20hereditary%20cancer%20syndromes.%20The%202005%20California%20Health%20Interview%20Survey&amp;author=MT%20Scheuner&amp;author=TS%20McNeel&amp;author=AN%20Freedman&amp;volume=12&amp;issue=11&amp;publication_year=2010&amp;pmid=20921897&amp;doi=10.1097/GIM.0b013e3181f30e9e&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B31">
<span class="label">31.</span><cite>
Ndiaye R, Diop JPD, Bourdon-Huguenin V, Dem A, Diouf D, Dieng MM, et al. Evidence for an ancient BRCA 1 pathogenic variant in inherited breast cancer patients from Senegal. NPJ Genom Med (2020) 5(1). doi: 10.1038/s41525-020-0114-7
</cite> [<a href="https://doi.org/10.1038/s41525-020-0114-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6994613/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32025337/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=NPJ%20Genom%20Med&amp;title=Evidence%20for%20an%20ancient%20BRCA%201%20pathogenic%20variant%20in%20inherited%20breast%20cancer%20patients%20from%20Senegal&amp;author=R%20Ndiaye&amp;author=JPD%20Diop&amp;author=V%20Bourdon-Huguenin&amp;author=A%20Dem&amp;author=D%20Diouf&amp;volume=5&amp;issue=1&amp;publication_year=2020&amp;pmid=32025337&amp;doi=10.1038/s41525-020-0114-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B32">
<span class="label">32.</span><cite>
Vargas E, Torres Lopez DM, Deugd R, Gil F, Nova A, Mora L, et al. Low prevalence of the four common Colombian founder mutations in BRCA1 and BRCA2 in early-onset and familial afro-Colombian patients with breast cancer. Oncologist (2019) 24(7):e475–9. doi: 10.1634/theoncologist.2018-0346
</cite> [<a href="https://doi.org/10.1634/theoncologist.2018-0346" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6656434/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30541753/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncologist&amp;title=Low%20prevalence%20of%20the%20four%20common%20Colombian%20founder%20mutations%20in%20BRCA1%20and%20BRCA2%20in%20early-onset%20and%20familial%20afro-Colombian%20patients%20with%20breast%20cancer&amp;author=E%20Vargas&amp;author=DM%20Torres%20Lopez&amp;author=R%20Deugd&amp;author=F%20Gil&amp;author=A%20Nova&amp;volume=24&amp;issue=7&amp;publication_year=2019&amp;pmid=30541753&amp;doi=10.1634/theoncologist.2018-0346&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B33">
<span class="label">33.</span><cite>
Herzog JS, Chavarri-Guerra Y, Castillo D, Abugattas J, Villarreal-Garza C, Sand S, et al. Genetic epidemiology of BRCA1- and BRCA2-associated cancer across Latin America. NPJ Breast Cancer (2021) 7(1). doi: 10.1038/s41523-021-00317-6
</cite> [<a href="https://doi.org/10.1038/s41523-021-00317-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8377150/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34413315/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=NPJ%20Breast%20Cancer&amp;title=Genetic%20epidemiology%20of%20BRCA1-%20and%20BRCA2-associated%20cancer%20across%20Latin%20America&amp;author=JS%20Herzog&amp;author=Y%20Chavarri-Guerra&amp;author=D%20Castillo&amp;author=J%20Abugattas&amp;author=C%20Villarreal-Garza&amp;volume=7&amp;issue=1&amp;publication_year=2021&amp;pmid=34413315&amp;doi=10.1038/s41523-021-00317-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B34">
<span class="label">34.</span><cite>
Molina J, Fernandez OOC, Lim M, Mas L, Veliz IF, Vargas C. BRCA 1/2 mutations in high-grade serous ovarian cancer (HGS-OC) patients of three Latin American countries: Report of 412 cases. J Clin Oncol (2019) 37(15_suppl):e14288–8. doi: 10.1200/JCO.2019.37.15_suppl.e14288
</cite> [<a href="https://doi.org/10.1200/JCO.2019.37.15_suppl.e14288" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=BRCA%201/2%20mutations%20in%20high-grade%20serous%20ovarian%20cancer%20(HGS-OC)%20patients%20of%20three%20Latin%20American%20countries:%20Report%20of%20412%20cases&amp;author=J%20Molina&amp;author=OOC%20Fernandez&amp;author=M%20Lim&amp;author=L%20Mas&amp;author=IF%20Veliz&amp;volume=37&amp;issue=15_suppl&amp;publication_year=2019&amp;doi=10.1200/JCO.2019.37.15_suppl.e14288&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B35">
<span class="label">35.</span><cite>
Jara L, Morales S, de Mayo T, Gonzalez-Hormazabal P, Carrasco V, Godoy R. Mutations in BRCA1, BRCA2 and other breast and ovarian cancer susceptibility genes in Central and South American populations. Biol Res (2017) 50(1). doi: 10.1186/s40659-017-0139-2
</cite> [<a href="https://doi.org/10.1186/s40659-017-0139-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6389095/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28985766/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biol%20Res&amp;title=Mutations%20in%20BRCA1,%20BRCA2%20and%20other%20breast%20and%20ovarian%20cancer%20susceptibility%20genes%20in%20Central%20and%20South%20American%20populations&amp;author=L%20Jara&amp;author=S%20Morales&amp;author=T%20de%20Mayo&amp;author=P%20Gonzalez-Hormazabal&amp;author=V%20Carrasco&amp;volume=50&amp;issue=1&amp;publication_year=2017&amp;pmid=28985766&amp;doi=10.1186/s40659-017-0139-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B36">
<span class="label">36.</span><cite>
Solano AR, Mele PG, Jalil FS, Liria NC, Podesta EJ, Gutiérrez LG. Study of the genetic variants in BRCA1/2 and non- BRCA genes in a population-based cohort of 2155 breast/ovary cancer patients, including 443 triple-negative breast cancer patients, in Argentina. Cancers (Basel) (2021) 13(11). doi: 10.3390/cancers13112711
</cite> [<a href="https://doi.org/10.3390/cancers13112711" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8198763/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34072659/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers%20(Basel)&amp;title=Study%20of%20the%20genetic%20variants%20in%20BRCA1/2%20and%20non-%20BRCA%20genes%20in%20a%20population-based%20cohort%20of%202155%20breast/ovary%20cancer%20patients,%20including%20443%20triple-negative%20breast%20cancer%20patients,%20in%20Argentina&amp;author=AR%20Solano&amp;author=PG%20Mele&amp;author=FS%20Jalil&amp;author=NC%20Liria&amp;author=EJ%20Podesta&amp;volume=13&amp;issue=11&amp;publication_year=2021&amp;pmid=34072659&amp;doi=10.3390/cancers13112711&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B37">
<span class="label">37.</span><cite>
Bhaskaran SP, Huang T, Rajendran BK, Guo M, Luo J, Qin Z, et al. Ethnic-specific BRCA1/2 variation within Asia population: evidence from over 78 000 cancer and 40 000 non-cancer cases of Indian, Chinese, Korean and Japanese populations. J Med Genet (2021) 58(11):752–9. doi: 10.1136/jmedgenet-2020-107299
</cite> [<a href="https://doi.org/10.1136/jmedgenet-2020-107299" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32963034/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Med%20Genet&amp;title=Ethnic-specific%20BRCA1/2%20variation%20within%20Asia%20population:%20evidence%20from%20over%2078%20000%20cancer%20and%2040%20000%20non-cancer%20cases%20of%20Indian,%20Chinese,%20Korean%20and%20Japanese%20populations&amp;author=SP%20Bhaskaran&amp;author=T%20Huang&amp;author=BK%20Rajendran&amp;author=M%20Guo&amp;author=J%20Luo&amp;volume=58&amp;issue=11&amp;publication_year=2021&amp;pmid=32963034&amp;doi=10.1136/jmedgenet-2020-107299&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B38">
<span class="label">38.</span><cite>
Kluz T, Jasiewicz A, Marczyk E, Jach R, Jakubowska A, Lubiński J, et al. Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland. Hered Cancer Clin Pract (2018) 16(1). doi: 10.1186/s13053-018-0089-x
</cite> [<a href="https://doi.org/10.1186/s13053-018-0089-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5828315/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29492181/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hered%20Cancer%20Clin%20Pract&amp;title=Frequency%20of%20BRCA1%20and%20BRCA2%20causative%20founder%20variants%20in%20ovarian%20cancer%20patients%20in%20South-East%20Poland&amp;author=T%20Kluz&amp;author=A%20Jasiewicz&amp;author=E%20Marczyk&amp;author=R%20Jach&amp;author=A%20Jakubowska&amp;volume=16&amp;issue=1&amp;publication_year=2018&amp;pmid=29492181&amp;doi=10.1186/s13053-018-0089-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B39">
<span class="label">39.</span><cite>
Kechin A, Boyarskikh U, Barinov A, Tanas A, Kazakova S, Zhevlova A, et al. A spectrum of BRCA1 and BRCA2 germline deleterious variants in ovarian cancer in Russia. Breast Cancer Res Treat (2023) 197(2):387–95. doi: 10.1007/s10549-022-06782-2
</cite> [<a href="https://doi.org/10.1007/s10549-022-06782-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36367610/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res%20Treat&amp;title=A%20spectrum%20of%20BRCA1%20and%20BRCA2%20germline%20deleterious%20variants%20in%20ovarian%20cancer%20in%20Russia&amp;author=A%20Kechin&amp;author=U%20Boyarskikh&amp;author=A%20Barinov&amp;author=A%20Tanas&amp;author=S%20Kazakova&amp;volume=197&amp;issue=2&amp;publication_year=2023&amp;pmid=36367610&amp;doi=10.1007/s10549-022-06782-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B40">
<span class="label">40.</span><cite>
Gabaldó Barrios X, Sarabia Meseguer MD, Marín Vera M, Sánchez Bermúdez AI, Macías Cerrolaza JA, Sánchez Henarejos P, et al. Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers. Fam Cancer (2017) 16(4):477–89. doi: 10.1007/s10689-017-9985-x
</cite> [<a href="https://doi.org/10.1007/s10689-017-9985-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28477318/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Fam%20Cancer&amp;title=Molecular%20characterization%20and%20clinical%20interpretation%20of%20BRCA1/BRCA2%20variants%20in%20families%20from%20Murcia%20(south-eastern%20Spain)%20with%20hereditary%20breast%20and%20ovarian%20cancer:%20clinical-pathological%20features%20in%20BRCA%20carriers%20and%20non-carriers&amp;author=X%20Gabald%C3%B3%20Barrios&amp;author=MD%20Sarabia%20Meseguer&amp;author=M%20Mar%C3%ADn%20Vera&amp;author=AI%20S%C3%A1nchez%20Berm%C3%BAdez&amp;author=JA%20Mac%C3%ADas%20Cerrolaza&amp;volume=16&amp;issue=4&amp;publication_year=2017&amp;pmid=28477318&amp;doi=10.1007/s10689-017-9985-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B41">
<span class="label">41.</span><cite>
Nguyen-Dumont T, Karpinski P, Sasiadek MM, Akopyan H, Steen JA, Theys D, et al. Genetic testing in Poland and Ukraine: should comprehensive germline testing of BRCA1 and BRCA2 be recommended for women with breast and ovarian cancer? Genet Res (Camb) (2020) 102. doi: 10.1017/S0016672320000075
</cite> [<a href="https://doi.org/10.1017/S0016672320000075" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7443769/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32772980/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet%20Res%20(Camb)&amp;title=Genetic%20testing%20in%20Poland%20and%20Ukraine:%20should%20comprehensive%20germline%20testing%20of%20BRCA1%20and%20BRCA2%20be%20recommended%20for%20women%20with%20breast%20and%20ovarian%20cancer&amp;author=T%20Nguyen-Dumont&amp;author=P%20Karpinski&amp;author=MM%20Sasiadek&amp;author=H%20Akopyan&amp;author=JA%20Steen&amp;volume=102&amp;publication_year=2020&amp;pmid=32772980&amp;doi=10.1017/S0016672320000075&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B42">
<span class="label">42.</span><cite>
Manzanares Campillo M, Muñoz Atienza V, Sánchez Tapia EM, Martín Fernández J. Portadoras de mutaciones en BRCA1 y 2 en familias de alto riesgo del área de Ciudad Real (España): prevalencia mutacional y características clínico-patológicas del cáncer de mama y ovario. Rev Senol Y Patol Mamaria J Breast Sci (2018) 31(2):59–66. doi:  10.1016/j.senol.2018.04.002
</cite> [<a href="https://doi.org/10.1016/j.senol.2018.04.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Rev%20Senol%20Y%20Patol%20Mamaria%20J%20Breast%20Sci&amp;title=Portadoras%20de%20mutaciones%20en%20BRCA1%20y%202%20en%20familias%20de%20alto%20riesgo%20del%20%C3%A1rea%20de%20Ciudad%20Real%20(Espa%C3%B1a):%20prevalencia%20mutacional%20y%20caracter%C3%ADsticas%20cl%C3%ADnico-patol%C3%B3gicas%20del%20c%C3%A1ncer%20de%20mama%20y%20ovario&amp;author=M%20Manzanares%20Campillo&amp;author=V%20Mu%C3%B1oz%20Atienza&amp;author=EM%20S%C3%A1nchez%20Tapia&amp;author=J%20Mart%C3%ADn%20Fern%C3%A1ndez&amp;volume=31&amp;issue=2&amp;publication_year=2018&amp;pages=59-66&amp;doi=10.1016/j.senol.2018.04.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B43">
<span class="label">43.</span><cite>
Kang PCE, Phuah SY, Sivanandan K, Kang IN, Thirthagiri E, Liu JJ, et al. Recurrent mutation testing of BRCA1 and BRCA2 in Asian breast cancer patients identify carriers in those with presumed low risk by family history. Breast Cancer Res Treat (2014) 144(3):635–42. doi: 10.1007/s10549-014-2894-x
</cite> [<a href="https://doi.org/10.1007/s10549-014-2894-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24578176/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res%20Treat&amp;title=Recurrent%20mutation%20testing%20of%20BRCA1%20and%20BRCA2%20in%20Asian%20breast%20cancer%20patients%20identify%20carriers%20in%20those%20with%20presumed%20low%20risk%20by%20family%20history&amp;author=PCE%20Kang&amp;author=SY%20Phuah&amp;author=K%20Sivanandan&amp;author=IN%20Kang&amp;author=E%20Thirthagiri&amp;volume=144&amp;issue=3&amp;publication_year=2014&amp;pmid=24578176&amp;doi=10.1007/s10549-014-2894-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B44">
<span class="label">44.</span><cite>
Gallardo-Rincón D, Montes-Servín E, Alamilla-García G, Montes-Servín E, Bahena-González A, Cetina-Pérez L, et al. Clinical benefits of olaparib in mexican ovarian cancer patients with founder mutation BRCA1-del ex9-12. Front Genet (2022) 13. doi:  10.3389/fgene.2022.863956
</cite> [<a href="https://doi.org/10.3389/fgene.2022.863956" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9207274/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35734436/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Genet&amp;title=Clinical%20benefits%20of%20olaparib%20in%20mexican%20ovarian%20cancer%20patients%20with%20founder%20mutation%20BRCA1-del%20ex9-12&amp;author=D%20Gallardo-Rinc%C3%B3n&amp;author=E%20Montes-Serv%C3%ADn&amp;author=G%20Alamilla-Garc%C3%ADa&amp;author=E%20Montes-Serv%C3%ADn&amp;author=A%20Bahena-Gonz%C3%A1lez&amp;volume=13&amp;publication_year=2022&amp;pmid=35734436&amp;doi=10.3389/fgene.2022.863956&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B45">
<span class="label">45.</span><cite>
Fernandes GC, Michelli RAD, Galvão HCR, Paula AE, Pereira R, Andrade CE, et al. Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry. Oncotarget (2016) 7(49):80465–81. doi: 10.18632/oncotarget.12610
</cite> [<a href="https://doi.org/10.18632/oncotarget.12610" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5348334/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27741520/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=Prevalence%20of%20BRCA1/BRCA2%20mutations%20in%20a%20Brazilian%20population%20sample%20at-risk%20for%20hereditary%20breast%20cancer%20and%20characterization%20of%20its%20genetic%20ancestry&amp;author=GC%20Fernandes&amp;author=RAD%20Michelli&amp;author=HCR%20Galv%C3%A3o&amp;author=AE%20Paula&amp;author=R%20Pereira&amp;volume=7&amp;issue=49&amp;publication_year=2016&amp;pmid=27741520&amp;doi=10.18632/oncotarget.12610&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B46">
<span class="label">46.</span><cite>
Jarhelle E, Riise Stensland HMF, Mæhle L, Van Ghelue M. Characterization of BRCA1 and BRCA2 variants found in a Norwegian breast or ovarian cancer cohort. Fam Cancer (2017) 16(1):1–16. doi: 10.1007/s10689-016-9916-2
</cite> [<a href="https://doi.org/10.1007/s10689-016-9916-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27495310/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Fam%20Cancer&amp;title=Characterization%20of%20BRCA1%20and%20BRCA2%20variants%20found%20in%20a%20Norwegian%20breast%20or%20ovarian%20cancer%20cohort&amp;author=E%20Jarhelle&amp;author=HMF%20Riise%20Stensland&amp;author=L%20M%C3%A6hle&amp;author=M%20Van%20Ghelue&amp;volume=16&amp;issue=1&amp;publication_year=2017&amp;pages=1-16&amp;pmid=27495310&amp;doi=10.1007/s10689-016-9916-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B47">
<span class="label">47.</span><cite>
Parsons MT, Tudini E, Li H, Hahnen E, Wappenschmidt B, Feliubadaló L, et al. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification. Hum Mutat (2019) 40(9):1557–78. doi:  10.1002/humu.23818
</cite> [<a href="https://doi.org/10.1002/humu.23818" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6772163/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31131967/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Mutat&amp;title=Large%20scale%20multifactorial%20likelihood%20quantitative%20analysis%20of%20BRCA1%20and%20BRCA2%20variants:%20An%20ENIGMA%20resource%20to%20support%20clinical%20variant%20classification&amp;author=MT%20Parsons&amp;author=E%20Tudini&amp;author=H%20Li&amp;author=E%20Hahnen&amp;author=B%20Wappenschmidt&amp;volume=40&amp;issue=9&amp;publication_year=2019&amp;pmid=31131967&amp;doi=10.1002/humu.23818&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B48">
<span class="label">48.</span><cite>
Ponce J, Vigil C, Araujo J, Castañeda C, Calderon G, Buleje J, et al. Abstract P5-09-08: Molecular evaluation of Peruvian patients with hereditary breast cancer reveals a novel germline mutation in BRCA1. Cancer Res (2017) 77(4_Supplement):P5-09-08. doi:  10.1158/1538-7445.SABCS16-P5-09-08
</cite> [<a href="https://doi.org/10.1158/1538-7445.SABCS16-P5-09-08" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&amp;title=Abstract%20P5-09-08:%20Molecular%20evaluation%20of%20Peruvian%20patients%20with%20hereditary%20breast%20cancer%20reveals%20a%20novel%20germline%20mutation%20in%20BRCA1&amp;author=J%20Ponce&amp;author=C%20Vigil&amp;author=J%20Araujo&amp;author=C%20Casta%C3%B1eda&amp;author=G%20Calderon&amp;volume=77&amp;issue=4_Supplement&amp;publication_year=2017&amp;pages=P5-09-08&amp;doi=10.1158/1538-7445.SABCS16-P5-09-08&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B49">
<span class="label">49.</span><cite>
Pal T, Bonner D, Cragun D, Monteiro ANA, Phelan C, Servais L, et al. A high frequency of BRCA mutations in young black women with breast cancer residing in Florida. Cancer (2015) 121(23):4173–80. doi: 10.1002/cncr.29645
</cite> [<a href="https://doi.org/10.1002/cncr.29645" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4666784/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26287763/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=A%20high%20frequency%20of%20BRCA%20mutations%20in%20young%20black%20women%20with%20breast%20cancer%20residing%20in%20Florida&amp;author=T%20Pal&amp;author=D%20Bonner&amp;author=D%20Cragun&amp;author=ANA%20Monteiro&amp;author=C%20Phelan&amp;volume=121&amp;issue=23&amp;publication_year=2015&amp;pmid=26287763&amp;doi=10.1002/cncr.29645&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B50">
<span class="label">50.</span><cite>
Díez O, Osorio A, Durán M, Martinez-Ferrandis JI, de la Hoya M, Salazar R, et al. Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects. Hum Mutat (2003) 22(4):301–12. doi: 10.1002/humu.10260
</cite> [<a href="https://doi.org/10.1002/humu.10260" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12955716/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Mutat&amp;title=Analysis%20of%20BRCA1%20and%20BRCA2%20genes%20in%20Spanish%20breast/ovarian%20cancer%20patients:%20a%20high%20proportion%20of%20mutations%20unique%20to%20Spain%20and%20evidence%20of%20founder%20effects&amp;author=O%20D%C3%ADez&amp;author=A%20Osorio&amp;author=M%20Dur%C3%A1n&amp;author=JI%20Martinez-Ferrandis&amp;author=M%20de%20la%20Hoya&amp;volume=22&amp;issue=4&amp;publication_year=2003&amp;pmid=12955716&amp;doi=10.1002/humu.10260&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B51">
<span class="label">51.</span><cite>
Iyevleva AG, Suspitsin EN, Kroeze K, Gorodnova TV, Sokolenko AP, Buslov KG, et al. Non-founder BRCA1 mutations in Russian breast cancer patients. Cancer Lett (2010) 298(2):258–63. doi: 10.1016/j.canlet.2010.07.013
</cite> [<a href="https://doi.org/10.1016/j.canlet.2010.07.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20727672/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Lett&amp;title=Non-founder%20BRCA1%20mutations%20in%20Russian%20breast%20cancer%20patients&amp;author=AG%20Iyevleva&amp;author=EN%20Suspitsin&amp;author=K%20Kroeze&amp;author=TV%20Gorodnova&amp;author=AP%20Sokolenko&amp;volume=298&amp;issue=2&amp;publication_year=2010&amp;pmid=20727672&amp;doi=10.1016/j.canlet.2010.07.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B52">
<span class="label">52.</span><cite>
Vidal AF, Ferraz RS, El-Husny A, Silva CS, Vinasco-Sandoval T, Magalhães L, et al. Comprehensive analysis of germline mutations in northern Brazil: a panel of 16 genes for hereditary cancer-predisposing syndrome investigation. BMC Cancer (2021) 21(1). doi: 10.1186/s12885-021-08089-9
</cite> [<a href="https://doi.org/10.1186/s12885-021-08089-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8028728/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33827469/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Cancer&amp;title=Comprehensive%20analysis%20of%20germline%20mutations%20in%20northern%20Brazil:%20a%20panel%20of%2016%20genes%20for%20hereditary%20cancer-predisposing%20syndrome%20investigation&amp;author=AF%20Vidal&amp;author=RS%20Ferraz&amp;author=A%20El-Husny&amp;author=CS%20Silva&amp;author=T%20Vinasco-Sandoval&amp;volume=21&amp;issue=1&amp;publication_year=2021&amp;pmid=33827469&amp;doi=10.1186/s12885-021-08089-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B53">
<span class="label">53.</span><cite>
Rogoża-Janiszewska E, Malińska K, Cybulski C, Jakubowska A, Gronwald J, Huzarski T, et al. Prevalence of recurrent mutations predisposing to breast cancer in early-onset breast cancer patients from Poland. Cancers (Basel) (2020) 12(8):1–10. doi:  10.3390/cancers12082321
</cite> [<a href="https://doi.org/10.3390/cancers12082321" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7465341/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32824581/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers%20(Basel)&amp;title=Prevalence%20of%20recurrent%20mutations%20predisposing%20to%20breast%20cancer%20in%20early-onset%20breast%20cancer%20patients%20from%20Poland&amp;author=E%20Rogo%C5%BCa-Janiszewska&amp;author=K%20Mali%C5%84ska&amp;author=C%20Cybulski&amp;author=A%20Jakubowska&amp;author=J%20Gronwald&amp;volume=12&amp;issue=8&amp;publication_year=2020&amp;pages=1-10&amp;pmid=32824581&amp;doi=10.3390/cancers12082321&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B54">
<span class="label">54.</span><cite>
Szwiec M, Jakubowska A, Górski B, Huzarski T, Tomiczek-Szwiec J, Gronwald J, et al. Recurrent mutations of BRCA1 and BRCA2 in Poland: an update. Clin Genet (2015) 87(3):288–92. doi: 10.1111/cge.12360
</cite> [<a href="https://doi.org/10.1111/cge.12360" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24528374/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Genet&amp;title=Recurrent%20mutations%20of%20BRCA1%20and%20BRCA2%20in%20Poland:%20an%20update&amp;author=M%20Szwiec&amp;author=A%20Jakubowska&amp;author=B%20G%C3%B3rski&amp;author=T%20Huzarski&amp;author=J%20Tomiczek-Szwiec&amp;volume=87&amp;issue=3&amp;publication_year=2015&amp;pmid=24528374&amp;doi=10.1111/cge.12360&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B55">
<span class="label">55.</span><cite>
Blay P, Santamaría I, Pitiot AS, Luque M, Alvarado MG, Lastra A, et al. Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain). BMC Cancer (2013) 13. doi: 10.1186/1471-2407-13-243
</cite> [<a href="https://doi.org/10.1186/1471-2407-13-243" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3662577/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23683081/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Cancer&amp;title=Mutational%20analysis%20of%20BRCA1%20and%20BRCA2%20in%20hereditary%20breast%20and%20ovarian%20cancer%20families%20from%20Asturias%20(Northern%20Spain)&amp;author=P%20Blay&amp;author=I%20Santamar%C3%ADa&amp;author=AS%20Pitiot&amp;author=M%20Luque&amp;author=MG%20Alvarado&amp;volume=13&amp;publication_year=2013&amp;pmid=23683081&amp;doi=10.1186/1471-2407-13-243&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B56">
<span class="label">56.</span><cite>
Kim JH, Park S, Park HS, Park JS, Lee ST, Kim SW, et al. Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study. Sci Rep (2021) 11(1). doi: 10.1038/s41598-021-87792-w
</cite> [<a href="https://doi.org/10.1038/s41598-021-87792-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8055990/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33875706/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=Analysis%20of%20BRCA1/2%20variants%20of%20unknown%20significance%20in%20the%20prospective%20Korean%20Hereditary%20Breast%20Cancer%20study&amp;author=JH%20Kim&amp;author=S%20Park&amp;author=HS%20Park&amp;author=JS%20Park&amp;author=ST%20Lee&amp;volume=11&amp;issue=1&amp;publication_year=2021&amp;pmid=33875706&amp;doi=10.1038/s41598-021-87792-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B57">
<span class="label">57.</span><cite>
Sakamoto I, Hirotsu Y, Nakagomi H, Ouchi H, Ikegami A, Teramoto K, et al. BRCA1 and BRCA2 mutations in Japanese patients with ovarian, fallopian tube, and primary peritoneal cancer. Cancer (2016) 122(1):84–90. doi: 10.1002/cncr.29707
</cite> [<a href="https://doi.org/10.1002/cncr.29707" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26439132/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=BRCA1%20and%20BRCA2%20mutations%20in%20Japanese%20patients%20with%20ovarian,%20fallopian%20tube,%20and%20primary%20peritoneal%20cancer&amp;author=I%20Sakamoto&amp;author=Y%20Hirotsu&amp;author=H%20Nakagomi&amp;author=H%20Ouchi&amp;author=A%20Ikegami&amp;volume=122&amp;issue=1&amp;publication_year=2016&amp;pages=84-90&amp;pmid=26439132&amp;doi=10.1002/cncr.29707&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B58">
<span class="label">58.</span><cite>
Yamaguchi-Kabata Y, Yasuda J, Tanabe O, Suzuki Y, Kawame H, Fuse N, et al. Evaluation of reported pathogenic variants and their frequencies in a Japanese population based on a whole-genome reference panel of 2049 individuals. J Hum Genet (2017) 63(2):213–30. doi:  10.1038/s10038-017-0347-1
</cite> [<a href="https://doi.org/10.1038/s10038-017-0347-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29192238/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Hum%20Genet&amp;title=Evaluation%20of%20reported%20pathogenic%20variants%20and%20their%20frequencies%20in%20a%20Japanese%20population%20based%20on%20a%20whole-genome%20reference%20panel%20of%202049%20individuals&amp;author=Y%20Yamaguchi-Kabata&amp;author=J%20Yasuda&amp;author=O%20Tanabe&amp;author=Y%20Suzuki&amp;author=H%20Kawame&amp;volume=63&amp;issue=2&amp;publication_year=2017&amp;pmid=29192238&amp;doi=10.1038/s10038-017-0347-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B59">
<span class="label">59.</span><cite>
Tokunaga H, Iida K, Hozawa A, Ogishima S, Watanabe Y, Shigeta S, et al. Novel candidates of pathogenic variants of the BRCA1 and BRCA2 genes from a dataset of 3,552 Japanese whole genomes (3.5KJPNv2). PloS One (2021) 16(1). doi: 10.1371/journal.pone.0236907
</cite> [<a href="https://doi.org/10.1371/journal.pone.0236907" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7799847/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33428613/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PloS%20One&amp;title=Novel%20candidates%20of%20pathogenic%20variants%20of%20the%20BRCA1%20and%20BRCA2%20genes%20from%20a%20dataset%20of%203,552%20Japanese%20whole%20genomes%20(3.5KJPNv2)&amp;author=H%20Tokunaga&amp;author=K%20Iida&amp;author=A%20Hozawa&amp;author=S%20Ogishima&amp;author=Y%20Watanabe&amp;volume=16&amp;issue=1&amp;publication_year=2021&amp;pmid=33428613&amp;doi=10.1371/journal.pone.0236907&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B60">
<span class="label">60.</span><cite>
Hirotsu Y, Nakagomi H, Sakamoto I, Amemiya K, Mochizuki H, Omata M. Detection of BRCA1 and BRCA2 germline mutations in Japanese population using next-generation sequencing. Mol Genet Genomic Med (2015) 3(2):121–9. doi: 10.1002/mgg3.120
</cite> [<a href="https://doi.org/10.1002/mgg3.120" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4367084/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25802882/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Genet%20Genomic%20Med&amp;title=Detection%20of%20BRCA1%20and%20BRCA2%20germline%20mutations%20in%20Japanese%20population%20using%20next-generation%20sequencing&amp;author=Y%20Hirotsu&amp;author=H%20Nakagomi&amp;author=I%20Sakamoto&amp;author=K%20Amemiya&amp;author=H%20Mochizuki&amp;volume=3&amp;issue=2&amp;publication_year=2015&amp;pmid=25802882&amp;doi=10.1002/mgg3.120&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B61">
<span class="label">61.</span><cite>
Torres-Mejía G, Royer R, Llacuachaqui M, Akbari MR, Giuliano AR, Martínez-Matsushita L, et al. Recurrent BRCA1 and BRCA2 mutations in Mexican women with breast cancer. Cancer Epidemiol Biomarkers Prev (2015) 24(3):498–505. doi: 10.1158/1055-9965.EPI-13-0980
</cite> [<a href="https://doi.org/10.1158/1055-9965.EPI-13-0980" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4495576/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25371446/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Epidemiol%20Biomarkers%20Prev&amp;title=Recurrent%20BRCA1%20and%20BRCA2%20mutations%20in%20Mexican%20women%20with%20breast%20cancer&amp;author=G%20Torres-Mej%C3%ADa&amp;author=R%20Royer&amp;author=M%20Llacuachaqui&amp;author=MR%20Akbari&amp;author=AR%20Giuliano&amp;volume=24&amp;issue=3&amp;publication_year=2015&amp;pages=498-505&amp;pmid=25371446&amp;doi=10.1158/1055-9965.EPI-13-0980&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/10470619/bin/Table_1.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (12.9KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/10470619/bin/Table_2.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (57.6KB, xlsx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/<a href="#SM1" class="usa-link">
<strong>Supplementary Material</strong>
</a>.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Frontiers in Oncology are provided here courtesy of <strong>Frontiers Media SA</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.3389/fonc.2023.1227864"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/fonc-13-1227864.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.2 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/10470619/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/10470619/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC10470619%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC10470619/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC10470619/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC10470619/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/37664050/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC10470619/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/37664050/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC10470619/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/10470619/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="i5awCN25rtwtBePDmzRUe5BLEfEqy1XDUfAJoFvDIb0NMkkECyfuLdurL73DBMs8">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
